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ABSTRACT 
Mechanical Properties of Bone Due to SOST Expression:  
A 3-Point Bending Assessment of Murine Femurs 
Kainoa John Peterson 
 
Sclerostin, a protein coded for by the SOST gene, is an osteocyte-expressed negative 
regulator of bone formation. The absence of SOST in the genome may have an effect on 
bone formation both during skeletal maturation and full maturity. This study attempts to 
determine significant differences in the mechanical properties of bone that expresses 
SOST compared to bone that does not. One hundred femur samples from  6, 8, and 12 
month old mice were obtained from Lawrence Livermore National Labs and loaded until 
failure using three-point bending. Results showed significant differences in treatment 
group effects for cross sectional area, yield force, and ultimate force. SOST knockout 
(KO) mice were found to have significantly higher values for these properties in 
comparison to transgenic (TG) and wildtype (WT) littermates. In addition, there was a 
noted effect dependent on the primary axis of loading, anterior-posterior versus medial-
lateral. Lastly, data from this study support the existing hypothesis that there is no 
systematic side-to-side (left-right) difference in bone formation. This data may aid 
understanding of the role SOST has in bone formation. If the structural integrity and 
quality of bone resulting from the removal of the SOST gene is shown to be comparable 
to that of normal, healthy bone, the use of gene therapy to combat diseases/disorders such 
as osteoporosis may lead to important contributions to medical therapy. 
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I. INTRODUCTION 
1.1 Bone Physiology 
The main functions of bone include locomotion, support of organs, protection, attachment 
sites for muscles, mineral homeostasis, and blood cell formation [1]. According to the 
primary locomotive function of the skeleton, mechanical competence of bones represents 
the ultimate measure of bone phenotype [2]. Structural rigidity of the skeleton is 
principally maintained by a mechanosensory feedback system that senses the loading 
induced deformations within the bones and copes with the locomotive challenges through 
modifications in bone size and shape [3]. New bone is laid on regions that are subject to 
loading that exceeds the customary loading range, whereas bone is removed from regions 
that experience reduced loading well below the customary loading range [4]. The cellular 
mechanisms involved in directing new bone formation to the high strain regions of a 
loaded bone are unclear. Further understanding of these mechanisms could provide an 
attractive target for pharmaceutical intervention aimed at mimicking the adaptive 
response to loading [5]. 
A simple yet effective means to enhance bone mass and architecture is through 
mechanical stimulation of the resident bone cell population [6-7]. Mechanical loading 
(e.g. exercise) improves bone mass and strength by stimulating the addition of new bone 
onto surfaces experiencing high strains, whereas surfaces that experience small strains 
remain largely quiescent [8]. In line with the established functional bone adaptation to 
loading, first described as Wolff’s Law, bones – as locomotive organs – adapt their 
structural rigidity and strength to incident loading through changes in structural 
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particulars (mineral mass, geometry, architecture, material properties) [4, 9]. Simplified, 
form follows function [10]. 
1.2 Bone Structure 
Bones are highly calcified structures which provide a support and protective function for 
the rest of the body. In addition to the structural framework and protective functions of 
bone, it also serves as a mineral reservoir for the rest of the body. Long bones make up 
the majority of bones and primarily consist of two different types; cortical and trabecular. 
These types of bone have differing structures which affect associated mechanical 
properties. 
1.2.1 Cortical Bone 
Cortical bone (Figure 1.1), also referred to as compact bone, is dense bone found in the 
shafts or diaphyses of long bone. This bone is characterized by low, 5-10%, porosity and 
is often tested to determine the mechanical properties of bone. Cortical bone is primarily 
made up of primary or secondary bone. The ratio of primary to secondary bone greatly 
affects the properties of the bone. The main structural component of this type of bone is 
the osteon which gives bone the ability to withstand torsion and bending stresses [11]. 
The remodeling of compact bone, or replacement of primary bone with secondary bone 
(discussed in Section 1.2.3.2), reduces its flexural fatigue strength and resistance to 
tension, compression, shear, and bending [12].  
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Figure 1.1. Representation of compact (cortical) and spongy (trabecular) bone in the 
femur. http://www.gla.ac.uk/ibls/US/fab/tutorial/generic/bone2.html 
1.2.2 Trabecular Bone 
Trabecular bone (Figure 1.1), also referred to as either cancellous or spongy bone, is 
characterized by largely spongeous and porous network. This type of bone is found at the 
ends or epiphyses of long bones and has a disorganized, random bone structure 
comprised of interconnected pores containing bone marrow which incorporate 
approximately 75-95% of trabecular bone volume [11]. Due to its porous structure, this 
type of bone is much weaker and more compliant than cortical bone. Mineral content and 
tissue density of cancellous bone have been found to be less than that of cortical bone 
[13-15]. The mechanical properties (e.g. modulus, strength, etc.) of trabecular bone are 
also different from those of cortical bone [16-18]. 
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1.2.3 Modeling and Remodeling of Bone 
Throughout life, bone is constantly changing. As the bone experiences greater or lesser 
forces, the overall structure is altered to maintain its level of function while using the 
least amount of bone material. This process of adaptation occurs in two different phases; 
modeling and remodeling. 
1.2.3.1 Bone Cells 
Bone is made up of cellular components which function to either form or resorb bone. 
Osteoclasts (Figure 1.2) resorb bone and are multinuclear cells formed by the fusion of 
monocytes which originate in the bone marrow. These cells respond to stresses or lack 
thereof and erode bone by demineralizing and dissolving the resulting collagen [11].  
The voids left behind following resorption by osteoclasts either remain quiescent due to 
lack of stresses or are filled with new bone formed by osteoblasts. Osteoblasts (Figure 
1.2) are mononuclear, cuboidal cells which respond to the presence of mechanical 
stresses. These cells are differentiated from mesenchymal cells and deposit the organic 
portion of bone matrix, osteoid [11]. 
Osteocytes (Figure 1.2) are terminally differentiated cells derived from osteoblasts, which 
first become embedded and surrounded by osteoid matrix that subsequently mineralizes 
[19]. These cells compose over 90-95% of all bone cells in the adult mammal [20]. 
Osteocytes are historically implicated with sensing and initiating mechanical signaling 
[8]. Thus, osteocytes have been regarded as the “mechano sensor” in bone [21-22]. 
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Figure 1.2. Bone cells and their role in the remodeling cycle. Hill 1998. 
1.2.3.2 Modeling versus Remodeling 
As long bones develop, they must increase in both diameter and length. However, as 
different stresses are applied to the bone, the formed bone must be shaped to continue 
properly performing its intended function. The process of removing bone in certain areas 
and replacing it with bone in others is known as bone modeling. Modeling as a whole 
involves independent actions of osteoclasts and osteoblasts, results in a change of bone 
size and/or shape, and occurs continuously at particular sites before skeletal maturity is 
reached. As bone experiences stresses, fatigue damage occurs and these regions of the 
bone must be repaired. The process of repairing resulting damage is known as remodeling 
(Figure 1.2). This is characterized by interaction between osteoblasts and osteoclasts, 
little to no change in the size and/or shape of bone, and continuous, episodic occurrence 
throughout life [11]. Thus, modeling is typically the formation of primary bone as the 
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body adjusts to the strains of growth, while remodeling creates secondary bone which 
serves to strengthen and repair damaged bone as fatigue and increased stresses are 
experienced by the bone following skeletal maturity. 
1.3 Bone Disorders 
There are a number of disorders which are attributed to altered modeling and remodeling 
of bone. A few of these disorders of interest to this project are osteoporosis, Van Buchem 
disease, and Sclerosteosis. 
1.3.1 Osteoporosis 
A consensus development conference statement defined osteoporosis as "a disease 
characterized by low bone mass and microarchitectural deterioration of bone tissue” [23]. 
The incident of low bone mass and poor bone structure are two major risk factors for 
osteoporotic fracture [24-25]. This condition is prevalent in the adult skeleton as bone 
remodeling becomes less efficient. In addition to skeletal abnormality causes for 
osteoporotic fracture, a variety of non-skeletal factors contribute to increased fracture 
risk, including trauma resulting from falls [26].  
Increased porosity associated with aging and osteoporosis is largely confined to the 
endosteal, inner, regions near the neutral axis of bone [11]. In recent years, a number of 
therapies have been developed to attempt to combat osteoporosis. Thus far there is no 
treatment that has been established to effectively mitigate the risks of osteoporosis, 
although recent research is attempting to develop better understanding of the gene 
networks regulating osteocytes which may provide a more efficient avenue for 
development of new therapies for osteoporosis [27]. 
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1.3.2 Van Buchem Disease 
Van Buchem is a homozygous recessive disorder [28-30] that results in progressive 
increase in bone density [31]. Van Buchem patients carry a homozygous 52kb non coding 
deletion ~35kb downstream of SOST (described in Section 1.4) transcript and ~10kb 
upstream of the downstream gene, MEOX1, on human chromosome 17p21 [29-30, 32]. 
Patient complications include vast accumulation of bone mass which gives rise to facial 
distortions, enlargement of the mandible and head, entrapment of the cranial nerves, 
increase in bone strength, and excessive weight [28-30]. There have been approximately 
40 reported cases of Van Buchem disease [33]. 
1.3.3 Sclerosteosis 
Sclerosteosis is a cranio-tubular hypersteosis that is phenotypically indistinguishable 
from Van Buchem disease except that it is more severe and occasionally displays 
syndactyly of the digits, a trait absent in Van Buchem disease [34-37]. Observed 
intracranial pressure sometimes leads to sudden death [38]. Shared clinical similarities 
between sclerosteosis and Van Buchem disease, along with their strong genetic linkage to 
the SOST locus on chromosome 17q12, suggest that they are allelic [39]. There have 
been less than 100 reported cases of patients experiencing this disease [33]. 
1.4 SOST/Sclerostin 
Sclerostin, a protein coded for by the SOST gene [40], is an osteocyte-expressed negative 
regulator of bone formation that is structurally most closely related to the DAN/Cerberus 
family of bone morphogenic protein (BMP) antagonists [41-42]. Mutations in the SOST 
gene, or in its distant regulatory elements, cause sclerosing bone disorders such as 
sclerosteosis and Van Buchem disease [29-30, 43].  
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Currently there is no clear understanding of how the lack of sclerostin promotes 
osteogenesis; therefore determining its transcriptional regulation is essential to 
understanding the interconnection between its expression in osteogenic cells and its 
mechanism of action either as a BMP antagonist [41] or Wnt antagonist [44]. Sclerostin 
was originally classified as a BMP antagonist because of its sequence homology to other 
members of the DAN family of cysteine knot proteins, but more recently has been shown 
to bind low-density lipoprotein receptor related protein 5/6 (LRP5/6) with high affinity 
[44-46]. 
Data suggest Wnt/LRP5 signaling is an integral part of the mechanotransduction cascade 
in normal bone tissue [47]. Recent research provides evidence that sclerostin is an 
indirect inhibitor of BMP, but specifically antagonizes the Wnt pathway [42] as an 
antagonist of LRP5, a gene shown to be important as a positive regulator of bone mass 
[44]. Additional support for the connection between SOST and Wnt signaling pathway is 
the regulation of both Wnt and SOST by mechanical strain in osteocytes [48].  
1.5 Use of Animal Models to Mimic Human Bone Disorders 
Due to ethical and logistic concerns, the use of human bones for research testing is 
limited. The need for effective methods to enhance bone repair persists and appropriate 
models are needed for evaluating new therapies. Despite problems resulting from their 
small size, mice have advantages over larger species that justify their introduction as 
models for skeletal research [49-50]. Genetic engineering has introduced an increasing 
number of transgenic mouse models with genetically modified skeletal functions [51]. 
The genetic factors that contribute to susceptibility to bone loss are extremely 
heterogeneous; therefore murine models that affect bone development and growth can 
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provide invaluable insights into the molecular mechanisms of progressive bone loss in 
humans [39]. 
Multiple bones have been used in mouse models with the tibia and femur being the most 
prevalent [52]. Although the tibia is easier to access than the femur, the tibia is not an 
ideal model for fracture studies because of its curved major axis which complicates 
mechanical testing [53-54]. The femur, however, is able to be positioned on the flat 
posterior surface, and thus is more conducive to repeatable biomechanical testing. A 
common concern with testing of murine bones is the small size, and while the murine 
femur is small in comparison to larger animal models, it is the largest long bone in the 
body, providing a testable region of cortical bone. Researchers view the femur as an 
exciting fracture model for modern orthopedic research [52]. 
1.6 Hybridization of Mice 
Researchers are continually creating new knockout (KO) or transgenic (TG) mouse 
models to explore the genetic basis of various skeletal traits [55]. Sclerostin deficiency in 
humans has the same phenotypic outcome regardless of sex and the phenotype of SOST 
KO mice was essentially the same across sexes with differences only in magnitude for 
some effects [56]. The effects of sclerostin deficiency on bone seen in the SOST KO 
mice are the opposite of and biologically consistent with the effects described for 
sclerostin overexpression in transgenic mice (Figure 1.3) [56]. 
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Figure 1.3. Increased BMD in SOST KO mice. (A) Whole body radiographs of 4-mo-old 
female WT and KO mice showing increased radiodensity throughout the skeleton of KO 
mice. (B) Enlargement of radiographs showing pelvic region. (C) Enlargement of 
radiographs showing skull. Li et al., 2008. 
 
Lawrence Livermore National Labs, located in Livermore, California, has discovered a 
novel function for sclerostin during limb development, demonstrating that Van Buchem 
(VB) disease is caused by the removal of bone-specific distant enhancer elements and is 
allelic to sclerosteosis [39]. These researchers have characterized human bacterial 
artificial chromosome (BAC) SOST transgenic mice carrying either a normal (SOSTwt) 
or an allele with the VB-associated deletion (SOSTvb∆). Only the SOSTwt allele 
faithfully expresses human SOST in the adult bone and has an impact on bone 
metabolism, consistent with the model that the VB noncoding deletion removes a SOST-
specific regulatory element [39]. All lines of SOSTwt transgenic animals reliably 
expressed human SOST in the mineralized bone of neonatal and adult mice (skull, rib, 
femur) while all SOSTvb∆ lines had dramatically reduced levels of human SOST mRNA 
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expression. All lines also expressed human SOST in adult kidney and heart (Figure 1.4) 
[39]. 
 
Figure 1.4. Generation and characterization of Van Buchem transgenic mouse models. 
(A) A 158-kb human BAC (SOSTwt) spanning SOST and MEOX1 was engineered using 
in vitro BAC recombination in Escherichia coli (Lee et al. 2001) by deleting the 52-kb 
noncoding region missing in VB patients (SOSTvb∆). Human SOST expression was 
analyzed by rtPCR in adult tissues (B), embryos (C), and measured by quantitative rtPCR 
in E10.5 embryos (D) from two independent lines of each SOSTwt and SOSTvb∆ 
transgene. Loots et al., 2005. 
 
Data from Loots et al. [39] demonstrate that in vivo, the VB allele confers dramatically 
reduced SOST expression in the adult bone and suggests the vb∆ contains essential bone-
specific enhancer elements. This data strengthens evidence that lack of SOST expression 
in vb∆ is due to a 52kb noncoding deletion opposed to an artifact due to transgene copy 
number or site-of-integration position effect. 
SOSTwt mice displayed decreased bone volume and mineral density at skeletal maturity. 
The SOSTvb∆ mice were indistinguishable from their non-transgenic litter mates and the 
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observed osteopenia was gene-dose dependent. The successful hybridization of these 
mice effectively shows that the SOST gene has an effect on bone formation in the 
mammalian skeleton, with overexpression of human SOST negatively modulating bone 
mass once skeletal maturity is reached [39]. 
1.6.1 Lawrence Livermore National Labs Mouse Treatment Groups 
Murine femur samples obtained from Lawrence Livermore National Labs were classified 
as one of two genotypes; SOST KO (knockout) or SOST TG (transgenic). SOST TG 
mice carried a bacterial artificial chromosome (BAC 209M4) which resulted in an 
overexpression of human SOST. Within the genotype grouping of SOST TG, there was a 
sub-breakdown of TG, DEF (animals with limb defects), and littermate WT (wild type) 
controls. The classification of TG or DEF was based on the presence of limb defects, 
which was assumed to be caused by higher levels of SOST transgenic expression in the 
DEF mice. SOST TG mice were hemizygous, signifying the integration of the BAC at a 
single site, while SOST DEF mice were offspring from the mating of two SOST TG 
mice. The SOST DEF mice were presumed to have twice the amount of human SOST 
expression in comparison to the SOST TG mice. The SOST KO genotype also had a sub-
breakdown consisting of KO and littermate WT controls. The SOST KO mice were 
homozygous for SOST deficiency and displayed high bone mass as previously 
characterized by Li et al [56]. Wild type mice were the control, non-transgenic littermates 
of the alleles described above; these mice had normal levels of mouse SOST expression.   
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1.7 Mechanical Testing of Bone 
The mechanical properties of bone can be determined by application of bending, 
torsional, tensile, compression and shear tests [57]. Although biomechanical testing of 
bones, similar to any other in vitro measurement, represents an oversimplification of the 
complexity of the actual in vivo situation, the intention is to test the skeletal structure of 
interest as closely as possible in terms of the predominant loading environment [9]. 
Material properties of mouse cortical bone are difficult to measure directly and are often 
estimated based on engineering theory and measurements of whole bone mechanical 
properties and cross sectional geometry [58-60]. There may be considerable error in 
estimating material properties because mouse bones do not meet the ideal conditions of 
the engineering theory, such as constant geometric and material properties along their 
length [61-62]. Despite the limitations, bench top testing of mouse bone serves as a useful 
tool for determining significant differences so long as testing procedures are conducted 
under consistent conditions. 
1.7.1 Three-Point Bending 
Mechanical testing can provide researchers with important information regarding 
properties of bone. A load-deformation test is conducted and results are recorded in 
deformation as a function of the applied load, typically tension, compression, torsion, or 
bending [11]. In recent bone research, the most frequently used method for 
characterization of long bone biomechanical properties of the appendicular skeleton is 3-
point bending of the femoral midshaft [2, 9]. This test, coupled with measured geometric 
dimensions can be extrapolated to give the resulting stress and strain experienced by the 
bone. From this information, the elastic modulus, stiffness, can be determined. These 
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measured material properties allow for bone stiffness and strength to be evaluated both 
with and without normalization for geometric effects. 
1.7.1.1 Rational for Testing 
The majority of 3-point bending tests are conducted in the anterior-posterior (AP) 
direction. The femur is usually placed onto the test apparatus on its flat posterior surface 
and tested in the AP direction due to anatomical and practical reasons [9]. Although this 
method of testing is considered the current “gold standard”, testing the bone in the 
medial-lateral (ML) direction would provide useful information regarding the maximum 
mechanical properties of the femur. Studies have been conducted to determine the 
feasibility of testing in the ML direction and results from Leppanen et al. [9] show no 
reason why the ML testing model cannot be applied to the mouse model. According to 
this study, testing should be carried out in the ML direction, otherwise, there remains a 
risk that some essential information regarding the effects of any intervention, particularly 
that of altered mechanical loading, on the femur structure and mechanical competence 
might be missed. Regarding biological validation, loading induced increase in bone cross 
sectional moment of inertia (CSMI) and structural strength solely seen in the ML 
direction provides proof of appropriateness of ML testing direction [9]. 
Along the principle of Wolff’s Law (previously described in Section 1.1), one can 
assume that the ML direction, given the widest diameter of the elliptic cross section of 
the midfemur (Figure 1.5), represents the apparent primary direction of skeletal 
adaptation to locomotive loading [63]. If true, the common AP testing direction of the 
femora can be argued suboptimal, and thus the testing should be carried out in the ML 
direction [9]. This assumption may be incomplete as useful information can be obtained 
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from both bending directions. The ML direction will provide values in the principle axis 
of loading and can be taken as the maximum strength of bone, while the AP direction can 
be used to determine reduced mechanical property limits. These reduced values are useful 
in the case of impact or trauma occurring in the non-principle axis of loading. Potential 
fractures may occur in this direction and if only ML data is obtained, inaccurate 
assumptions may be made regarding the forces which bone can withstand. This is further 
supported by the finding that whole bone bending provides a measure at the continuum 
scale and is strongly influenced by porosity [64-65]. Since the porosity of bone may vary 
between the primary and non-primary axis of loading, conducting testing in both 
directions is necessary to provide a complete picture of the mechanical properties of 
bone. 
 
Figure 1.5. Anterior-Posterior (AP) and Medial-Lateral (ML) testing directions. 
 
There has been concern regarding differences between right and left leg analysis. Current 
approaches make an inherent assumption that right-to-left biomechanical properties and 
geometry of femora are equal, which may not be entirely accurate [66-67]. However it 
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can be anticipated that, under normal circumstances, there is no systematic difference 
between structural and mechanical characteristics of right and left femora [9]. One group 
attempted to determine the repeatability of biomechanical testing of rat femora by 
comparing data from left and right femora of nonoperated rats. Following this study, 
there was no indication of systematic side to side differences between right and left 
femora [9]. 
1.7.1.2 Testing Conditions 
As described in Section 1.6, 3-point bending has been readily used for the biomechanical 
testing of bones. There are conditions which are maintained in the majority of these tests 
including removal of all soft tissue from the bone, wrapping bones in a saline-soaked 
gauze bandage to prevent dehydration, and storage at −20°C until testing. This procedure 
has been shown not to affect the mechanical properties of bone [68-69]. It has been 
shown that the elastic modulus of bone is quite sensitive to its mineral content [70] and 
that the ionic content of storage baths can alter the mechanical properties of bone [71]. 
Some fatigue tests which last up to a few hours may not require a calcium buffering bath, 
however, experiments done at physiologic strains and under the best simulation of in vivo 
conditions will result in greater clinical significance and thus bone samples should be 
kept moist while undergoing short testing procedures [72]. Support placement for AP 
testing is located beneath the distal head of the femur and at 90° rotation from the greater 
trochanter, while ML testing support placement is located under greater trochanter and at 
90° rotation to the distal femur head (Figure 1.6). 
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Figure 1.6. (A) Three-point bending in the mediolateral direction. Side and top view. (B) 
Three-point bending in the anteroposterior direction. Side and top view. Leppanen et al., 
2006. 
 
 
Although storage conditions and testing orientations are commonly conducted uniformly 
between studies, the loading rate and distance between the supports varies between 
research groups. Loading rates of 1.0 mm/sec [9] and 0.03 mm/sec [73] have been 
reported in previous studies. Support gap distances also vary, but are within a confined 
range of values due to the fairly consistent length of murine femurs. Gaps of 6 mm [56], 
7 mm [52], and 10 mm [74] have been reported. 
1.8 Study Goals 
The goals of this study are to determine any mechanical property differences between the 
various murine treatment groups described in Section 1.6.1, as determined by 3-point 
bending. Mechanical properties for comparison have been discussed in Section 1.7.1 and 
include modulus, stress, and strain. Additional goals include determination of the effect 
of age and bend direction (AP versus ML) on the mechanical properties along with any 
resulting geometric differences of the tested murine femurs. Data from this study should 
aid current, ongoing research by providing laboratory data regarding the mechanical 
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properties of mice hybridized by Lawrence Livermore National Labs. Determination of 
significant differences in the strength of bone which does or does not express the SOST 
gene can support useful follow on research which may result in potential new gene 
therapies targeted for the treatment of osteoporosis. 
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II. MATERIALS AND METHODS 
100 murine hindlimbs were obtained from Lawrence Livermore National Labs (LLNL) 
located in Livermore, California. Mice were hybridized to display various geneotypes 
and phenotypes (SOST TG/DEF/WT 6 month, SOST TG/DEF/WT 8 month, SOST 
KO/WT 6 month, SOST KO/WT 12 month) at LLNL (Table 1, full breakdown of mouse 
numbers and treatments can be found in Appendix A). SOST transgenic (TG), wild type 
(WT), and deficient (DEF) mice were Friend leukemia virus B (FVB) mixed with 
C57/Bl/6J, backcrossed 4 generations to C57/Bl/6J while SOST knockout (KO) and wild 
types (WT) were a mixture of C57/Bl/6J and 129 background, primarily showing body 
characteristics of the 129 strain. Femurs of both the left and right legs were dissected 
from the remaining portion of the hindlimb and were cleansed of any remaining soft 
tissue that may have had an effect on the mechanical testing. Bones were wrapped in 
phosphate buffered saline (PBS) soaked gauze and stored in individually labeled vials in 
a sub-zero, -20°C, freezer until the time of testing. Samples were removed from the 
freezer one at a time and allowed to thaw until ready for testing.  
Table 1. Treatment Group Distribution 
Treatment Group Number of Mice Description 
SOST TG 6 month 2 Express human SOST. 
SOST DEF 6 month  9 Express twice the amount of human SOST as TG. 
WT 1 11 6 month old wildtype littermates of SOST TG/DEF mice.  Faithfully express murine SOST. 
SOST TG 8 month 2 Express human SOST. 
SOST DEF 8 month 4 Express twice the amount of human SOST as TG. 
WT 2 4 8 month old wildtype littermates of SOST TG/DEF mice.  Faithfully express murine SOST. 
SOST KO 6 month 5 Do not express any SOST. 
WT 3 6 6 month old wildtype littermates of SOST KO mice.  Faithfully express murine SOST. 
SOST KO 12 month 5 Do not express any SOST. 
WT 4 2 12 month old wildtype littermates of SOST KO mice.  Faithfully express murine SOST. 
TOTAL 50 - 
20 
 
2.1 Selection of Testing Direction 
3-point bending tests are commonly carried out with testing occurring in the anterior-
posterior (AP) direction. Since the medial-lateral (ML) diameter of bones is larger and 
more robust, as it is the principal axis of load bearing, it has been speculated that testing 
should be done in this direction [9].  To allow for a complete analysis of mechanical 
property differences in the various bone treatment types femurs were tested in both AP 
and ML directions (Figure 2.1). Each femur was randomly assigned a bend direction 
using Minitab 16 Statistical Software resulting in 50 bones being broken AP and 50 
bones broken ML. In order to make relevant and accurate comparisons of these testing 
orientations, one femur from each mouse (right or left) was broken in the AP direction 
while the other was done in the ML direction. 
 
Figure 2.1: A cross section view of the femur with labeling of anatomical locations. A: 
Anterior, P: Posterior, M: Medial, L: Lateral. 
2.2 Three-Point Bending 
Once thawed, bones were measured and marked at the midpoint of the length for 
identification of probe (load) location under a microscope and placed in a fixture to allow 
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for three-point bending of samples (Figure 2.4a). The 3-point bending apparatus (Figure 
2.2) was linked to a computer and needed calibration to ensure proper testing location 
(Figure 2.3). A computer program written by Dr. Lanny Griffin was used to calibrate the 
testing procedure and allowed for customization of testing parameters (testing speed and 
probe distance moved). Measurement Velocity was set to 20,000 nm/second (1.2 
mm/min) and the Max Probe Displacement was 1,000 µm (74). During the testing 
procedure, bones were kept moist using a phosphate buffered solution to help account for 
a more physiologic condition of bone. The test was conducted (Figure 2.4b depicts a test 
in progress), resulting in stored values of force and displacement for the time which bone 
was contacted by the measurement probe. These values were exported as .FIB files, 
analyzed using MATLAB, and imported into Microsoft Excel for creation of graphical 
representations of force and displacement.  
 
Figure 2.2: Three-point bend apparatus and computer used for calibration and data 
capture. 
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Figure 2.3: Microscope image of bone place in holding tray during programming of three 
point bend test. 
 
Figure 2.4: A) Applied force points during a three-point bend test [75]. B) Three-point 
bend test in progress at time of impact between probe and bone. 
Immediately following testing, broken femur halves were removed from the apparatus 
and bone marrow was removed using fine tipped forceps (Figure 2.5). Bones were then 
placed in a custom made holding fixture (Figure 2.6) to allow for diameter measurements 
to be taken under a microscope. Anterior-posterior and medial-lateral inner and outer 
diameters were measured for later use in data analysis. Measurements were taken with 
the use of a crosshair reticle and a moveable stage controlled by micromanipulators. The 
center of the crosshair was positioned at either the inner or outer edge of the bone and the 
A 
B
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stage was moved to the opposite edge. The amount of movement was recorded by the 
micromanipulator and the resulting value was recorded. This process was used opposed 
to imaging and analysis with Image J due to limitations of the camera/microscope system. 
Following measurement, bones were wrapped in PBS soaked gauze and re-frozen until 
embedding in epoxy, which would allow for additional analyses to be performed. 
 
Figure 2.5: Marrow extraction following three-point bend test using fine tip forceps. 
 
Figure 2.6: Custom fabricated bone holding fixture for analysis of fracture surface. 
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2.3 Data Analysis 
Design parameters of a MATLAB code were developed and the working code was 
written with the help of an undergraduate student, Brian Daugherty. Individual mouse 
data was compiled based on treatment type and compared to identify important 
differences in mechanical properties. Load maximum and yield points were determined 
from the force data obtained during testing and allowed for calculation of post-yield 
displacement as defined by the distance moved by the measurement probe between yield 
and fracture (see Appendix B for code). Figure 2.7 depicts an example graph of force 
versus displacement for each bone in a given treatment group while Figure 2.8 shows the 
measured values from this graph. 
Using obtained geometric and testing data, stress and strain values were calculated using 
the following mathematical equations [76]:  
Stress  
ߪ ൌ ெ௬ூ ൌ ቆ൬ܨ ∗ ቀ
ௗ
ସቁ൰ ∗
஺௉௢
ଶ ቇ /ܫݔݔ for bones broken in AP direction.  
or 
ߪ ൌ ெ௬ூ ൌ ቆ൬ܨ ∗ ቀ
ௗ
ସቁ൰ ∗
ெ௅௢
ଶ ቇ /ܫݔݔ for bones broken in ML direction. 
Strain 
ߝ ൌ ሺ12ݔ ∗ ሺ஺௉௢ଶ ሻሻ/݀ଶ for bones broken in AP direction. 
or 
ߝ ൌ ሺ12ݔ ∗ ሺெ௅௢ଶ ሻሻ/݀ଶ for bones broken in ML direction. 
Elastic modulus was calculated using a best fit to the slope of the stress-strain curve until 
yield. Yield stress was calculated with a 0.2% offset from 0 strain using the slope of the 
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elastic modulus [76]. Ultimate stress was determined using the MATLAB code in the 
same fashion as the maximum loads. Figure 2.9 depicts an example graph of stress versus 
strain (see Appendix B for code).  
The following mathematical equations were used for CSA and Ixx calculation [76-77]:  
Cross Sectional Area 
ܥܵܣ ൌ ቀߨ4ቁ ∗ ሺሺܣܲ݋ ∗ ܯܮ݋ሻ െ ሺܣܲ݅ ∗ ܯܮ݅ሻሻ 
Area Moment of Inertia 
ܫݔݔ ൌ ቀ గ଺ସቁ ∗ ቀ൫ܯܮ݋ ∗ ሺܣܲ݋ଷሻ൯ െ ൫ܯܮ݅ ∗ ሺܣܲ݅ଷሻ൯ቁ for bones broken in AP direction. 
or 
ܫݔݔ ൌ ቀ గ଺ସቁ ∗ ቀ൫ܣܲ݋ ∗ ሺܯܮ݋ଷሻ൯ െ ൫ܣܲ݅ ∗ ሺܯܮ݅ଷሻ൯ቁ for bones broken in ML direction 
The following list details the definition of symbols used above: 
APi = inner diameter in anterior-posterior direction 
APo = outer diameter in anterior-posterior direction 
CSA = cross sectional area 
d = distance between supports 
E = elastic modulus 
ε = strain 
F = force 
I and Ixx = area moment of inertia 
MLi = inner diameter in medial-lateral direction 
MLo = outer diameter in medial-lateral direction 
σ = stress 
x = measurement probe displacement 
y = distance from farthest point in cross section from neutral axis 
26 
 
 
Figure 2.7: Force versus displacement graph for right legs of 6 month SOST KO mice. 
 
Figure 2.8: MatLab output graph of force versus displacement. Point A marks the yield 
force, point B marks the ultimate force, and the distance between points A and fracture is 
the post-yield displacement. 
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Figure 2.9: Stress versus strain graph for left legs of 6 month SOST TG mice. 
2.3.1 Statistical Analysis 
Minitab 16 Statistical Software was used for the statistical analysis. Compiled data was 
organized by mouse treatment type, bend direction, and leg. Each effect (CSA, Ixx, E, 
yield force, ultimate force, yield stress, ultimate stress, post-yield displacement) was 
compared for statistical significance between the treatment groups listed in Table 1 (i.e. 
SOST KO 6 month versus SOST TG 6 month versus etc.).  
Initially, a general linear model (GLM) was run with three-way interactions including 
treatment group, bend direction, and leg (left or right). However, due to the absence of 
replication in a few of the treatment groups, one of these factors was left out of 
subsequent analyses. For CSA and Ixx the GLM was run with the two-way interaction of 
treatment group and leg. Bend direction was excluded due to the assumption that this 
factor would not affect the outcome of bone geometry. For the remaining analyses, leg 
was excluded and bend direction was included in the GLM, as this testing parameter was 
hypothesized to significantly affect the resulting data. 
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Prior to running of the GLM, a test for equal variances was performed. This test verified 
or discounted the assumption that variances were equal. Following this test, a test for 
normality was conducted on the standardized residuals to check the assumption that the 
data was distributed normally. Any outliers, as defined by a standard residual value 
>2.75, were excluded from the data set in an attempt to regain a normal distribution. 
Once equal variances and normal distribution were checked and outliers excluded, the 
GLM was run with the inclusion of Tukey comparison groups at a 95% confidence 
interval to determine the significant effect that treatment type and the secondary variable 
of either leg or bend direction had on the desired parameter. Residual and interaction 
plots were generated to help visually show any differences. All Minitab outputs can be 
found in Appendix C.  
There was one data file (for bone 8007L) which was corrupted and could not be salvaged. 
As such all data from this bone was not included in the statistical analysis. In addition, 
one bone set (9200L/R) was lost due to improper testing and data collection. 
2.4 Post Analysis 
Three-point bending generally results in an oblique fracture which is not suitable for 
analysis techniques such as nanoindentation. In order to allow for future work to be 
conducted on the samples, bones were embedded in epoxy and metallographically 
polished to an appropriate level of smoothness that would be suitable for 
nanoindentation. A description of the embedding and polishing is located in Appendix D. 
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III. RESULTS 
Following three-point bending, proximal bone halves were measured for geometric data. 
Using data obtained during testing and measurement, values were calculated for CSA, 
Ixx, E, yield force, ultimate force, post-yield displacement, yield stress, and ultimate 
stress. Data was organized by treatment group and each group was compared versus the 
other treatments. The information below shows the results of treatment groups based 
upon the criteria specified. It was hypothesized that either bend direction or leg (left or 
right) would have a significant effect on some of the comparisons and as such, these 
parameters were compared for interaction with the treatment type (labeled 
Genotype+Phenotype below). Complete Minitab outputs and graphs for all comparisons 
can be found in the appendix. 
3.1 Cross Sectional Area 
Cross sectional area was predicted to be only affected by the treatment type. No effect 
was predicted for the difference between left and right hindlimbs as it is not known for 
mice to have a dominant limb. Leg was included in the analysis and bend direction was 
excluded as mechanical testing direction has no effect on cross sectional area. Three 
values had standardized residuals of greater than ±2.75 and were excluded from the 
analysis for normality. Figure 3.1 shows the associated p-values for the general linear 
model (GLM) analysis for this data set. Figure 3.2 displays the different treatment groups 
and their associated means and significantly different groupings, as determined by a 
Tukey’s comparison with a 95% confidence interval. 
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Figure 3.1: GLM of cross sectional area across treatment groups and associated p-values. 
Data shown reflects statistical analysis and excludes 3 outlier values. 
 
Figure 3.2: Treatment group averages and significantly different value groupings for 
cross sectional area. Data shown reflects statistical analysis and excludes 3 outlier values. 
WT 1-4 are control littermates of SOST TG 6 month, SOST TG 8 month, SOST KO 6 
month, and SOST KO 12 month respectively. These mice faithfully express murine 
SOST. 
The treatment group was determined to be the only factor which significantly affected 
cross sectional area (CSA) (p = 0.00). There was not a significant interaction between 
treatment group and the leg broken. Observations from these results show that there was 
no significant difference between any treatment groups of 6 month old SOST TG, SOST 
DEF, and and their control littermate (WT 1) mice (Figure 3.3). This observation was 
also true for the 8 month old SOST TG, DEF, and their control littermate (WT 2) mice 
(Figure 3.4). There was also no significant difference between these two age groups 
(Figure 3.8). Opposite of these observations, there were significant differences between 
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both 6 and 12 month SOST KO mice and their respective wildtype  (WT) control 
littermates (Figures 3.5 and 3.6). Interestingly, there was also a difference found between 
6 month old WT for the SOST TG and SOST KO littermates (WT 1 and WT 3) (Figure 
3.7).  
Figure 3.3: Histogram displaying the comparison of cross sectional area for 6 month old 
SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.4: Histogram displaying the comparison of cross sectional area for 8 month old 
SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
0.00E+00
2.00E‐01
4.00E‐01
6.00E‐01
8.00E‐01
1.00E+00
1.20E+00
1.40E+00
CS
A (
m
m
^2
)
Treatment Group
Cross Sectional Area for 6 month SOST TG 
Mice
SOST DEF 6 month
SOST TG 6 month
WT 1
0.00E+00
2.00E‐01
4.00E‐01
6.00E‐01
8.00E‐01
1.00E+00
1.20E+00
1.40E+00
CS
A (
m
m
^2
)
Treatment Group
Cross Sectional Area for 8 month SOST TG 
Mice
SOST DEF 8 month
SOST TG 8 month
WT 2
32 
 
Figure 3.5: Histogram displaying the comparison of cross sectional area for 6 month old 
SOST Knockout mice. WT 3 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.6: Histogram displaying the comparison of cross sectional area for 12 month old 
SOST Knockout mice. WT 4 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.7: Histogram displaying the comparison of cross sectional area for 6 month old 
mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
Figure 3.8: Histogram displaying the comparison of cross sectional area for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
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Figure 3.9: Histogram displaying the comparison of cross sectional area for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
3.2 Area Moment of Inertia 
Area moment of inertia was predicted to be significantly affected by only the treatment 
type. The bone formation differences were predicted to be the cause of this difference. 
The leg (left or right) was not predicted to have an influence on the outcome of the test. 
One value had a standardized residual of greater than ±2.75 and was excluded from the 
analysis for normality. Figure 3.10 shows the associated p-values for the general linear 
model (GLM) analysis for this data set. Figures 3.11 and 3.12 display the different 
treatment groups and leg distributions along with their associated means and significantly 
different groupings, as determined by a Tukey’s comparison with a 95% confidence 
interval. 
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Figure 3.10: GLM of area moment of inertia across treatment groups and associated p-
values. Data shown reflects statistical analysis and excludes 1 outlier value. 
 
Figure 3.11: Treatment group averages and significantly different value groupings for 
area moment of inertia. Data shown reflects statistical analysis and excludes 1 outlier 
value. WT 1-4 are control littermates of SOST TG 6 month, SOST TG 8 month, SOST 
KO 6 month, and SOST KO 12 month respectively. These mice faithfully express murine 
SOST. 
 
Figure 3.12: Average values by leg and significantly different value groupings for area 
moment of inertia. Data shown reflects statistical analysis and excludes 1 outlier value. 
The treatment group was determined to be the only factor which significantly affected the 
area moment of inertia (Ixx) (p = 0.00). There was, however, a marginally significant 
effect due to the leg (left or right) broken (p = 0.072). There was not a significant 
interaction between treatment group and the leg broken. Observations from these results 
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show that there was no significant difference between any treatment groups of 6 month 
old SOST TG, SOST DEF, and their control littermate (WT 1) mice (Figure 3.13). This 
observation was also true for the 8 month old SOST TG, DEF, and their control littermate 
(WT 2) mice (Figure 3.14). There was also no significant difference between these two 
age groups (Figure 3.18). Opposite of these observations, there was a significant 
difference between 12 month SOST KO mice and their WT control littermates (Figure 
3.16). Interestingly, there was no difference found between 6 month old SOST KO and 
WT littermates (Figure 3.15). 
Figure 3.13: Histogram displaying the comparison of area moment of inertia for 6 month 
old SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.14: Histogram displaying the comparison of area moment of inertia for 6 month 
old SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.15: Histogram displaying the comparison of area moment of inertia for 6 month 
old SOST Knockout mice. WT 3 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.16: Histogram displaying the comparison of area moment of inertia for 12 
month old SOST Knockout mice. WT 4 mice were control littermates and faithfully 
express murine SOST. No animals were excluded from this analysis. 
Figure 3.17: Histogram displaying the comparison of area moment of inertia for 6 month 
old mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
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Figure 3.18: Histogram displaying the comparison of area moment of inertia for 6 month 
old Transgenic mice and 8 month old Transgenic mice. Wild type controls were not 
included in this analysis. 
Figure 3.19: Histogram displaying the comparison of area moment of inertia for 6 month 
old Knockout mice and 12 month old Knockout mice. Wild type controls were not 
included in this analysis. 
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Figure 3.20: Histogram of the average values of area moment of inertia for all bones in 
by leg. 
3.3 Elastic Modulus 
Elastic modulus was predicted to be significantly affected by both treatment type and 
bend direction. Bone formation differences between the treatment groups along with the 
difference in principle axis of loading between anterior-posterior (AP) and medial-lateral 
(ML) were the predicted reasons for this difference. The leg (left or right) was not 
predicted to have an influence on the outcome of the test and as such was replaced with 
bend direction in the GLM. There were two values at a standard residual of 2.81 and -
2.81 respectively. These values were determined to be marginal outliers, and were 
included in the analysis. Figure 3.21 shows the associated p-values for the general linear 
model (GLM) analysis for this data set. Figures 3.22 and 3.23 display the different 
treatment groups and bend directions with associated means and significantly different 
groupings, as determined by a Tukey’s comparison with a 95% confidence interval.  
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Figure 3.21: GLM of elastic modulus across treatment groups and associated p-values. 
There were no outliers in the data set. 
 
Figure 3.22: Treatment group averages and significantly different value groupings for 
elastic modulus. There were no outliers in the data set. WT 1-4 are control littermates of 
SOST TG 6 month, SOST TG 8 month, SOST KO 6 month, and SOST KO 12 month 
respectively. These mice faithfully express murine SOST. 
 
Figure 3.23: Bend direction averages and significantly different value groupings for 
elastic modulus. There were no outliers in the data set. 
Both treatment group (p = 0.00) and bend direction (p = 0.00) were determined to 
significantly affect the modulus (E) individually. There was not a significant interaction 
between treatment group and the bend direction. Observations from these results show 
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that there was no significant difference in elastic modulus between treatment groups of 6 
month old SOST TG,  SOST DEF, and their control littermate (WT 1) mice (Figure 
3.24). This observation was also true for the 8 month old SOST TG, DEF, and their 
control littermate (WT 2) mice (Figure 3.25). There was also no significant difference 
between these two age groups (Figure 3.29). Interestingly, there was no difference in 
elastic modulus found between 6 and 12 month old SOST KO mice, nor their respective 
WT littermates (WT3 and WT4) (Figures 3.26, 3.27, and 3.30). 
Figure 3.24: Histogram displaying the comparison of elastic modulus for 6 month old 
SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.25: Histogram displaying the comparison of elastic modulus for 8 month old 
SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.26: Histogram displaying the comparison of elastic modulus for 6 month old 
SOST Knockout mice. WT 3 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
0.00E+00
1.00E+00
2.00E+00
3.00E+00
4.00E+00
5.00E+00
6.00E+00
7.00E+00
8.00E+00
9.00E+00
1.00E+01
E (
Gp
a)
Treatment Group
Elastic Modulus for 8 month SOST TG Mice
SOST DEF 8 month
SOST TG 8 month
WT 2
0.00E+00
5.00E‐01
1.00E+00
1.50E+00
2.00E+00
2.50E+00
3.00E+00
3.50E+00
4.00E+00
E (
Gp
a)
Treatment Group
Elastic Modulus for 6 month SOST KO Mice
SOST KO 6 month
WT 3
44 
 
Figure 3.27: Histogram displaying the comparison of elastic modulus for 12 month old 
SOST Knockout mice. WT 4 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.28: Histogram displaying the comparison of elastic modulus for 6 month old 
mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
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Figure 3.29: Histogram displaying the comparison of elastic modulus for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
Figure 3.30: Histogram displaying the comparison of elastic modulus for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
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Figure 3.31: Histogram of the average values of elastic modulus for all bones by bend 
direction. AP: anterior-posterior; ML: medial-lateral. 
3.4 Yield Force 
Yield force was predicted to be significantly affected by both treatment type and bend 
direction. Bone formation differences between the treatment groups along with the 
difference in principle axis of loading between anterior-posterior (AP) and medial-lateral 
(ML) directions were the hypothesized reasons for this variation. The leg (left or right) 
was not predicted to have an influence on the outcome of the test. Three values had 
standardized residuals of greater than ±2.75 and were excluded from the analysis for 
normality. Figure 3.32 shows the associated p-values for the general linear model (GLM) 
analysis for this data set. Figure 3.33 displays the interaction between different treatment 
groups and bend direction along with associated means and significantly different 
groupings, as determined by a Tukey’s comparison with a 95% confidence interval.  
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Figure 3.32: GLM of yield force across treatment groups and associated p-values. Data 
shown reflects statistical analysis and excludes 3 outlier values. 
 
Figure 3.33: Treatment group averages and significantly different value groupings for 
yield force. Data shown reflects statistical analysis and excludes 3 outlier values. WT 1-4 
are control littermates of SOST TG 6 month, SOST TG 8 month, SOST KO 6 month, and 
SOST KO 12 month respectively. These mice faithfully express murine SOST. 
Individually, both treatment group (p = 0.00) and bend direction (p = 0.00) were 
determined to significantly affect the yield force. There was also a significant interaction 
between the combination of treatment group and bend direction (p = 0.00). Observations 
from these results show that there was no significant difference caused by the interaction 
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of treatment group and bend direction between 6 month old SOST TG, SOST DEF, and 
their control littermate (WT 1) mice (Figure 3.42). This observation was also true for the 
8 month old SOST TG, DEF, and their control littermate (WT 2) mice (Figure 3.43). 
There was also no significant difference between these two age groups (Figure 3.47). The 
yield force of the bones broken in the AP and ML bend direction for the 12 month SOST 
KO mice were statistically equivalent to each other as well as the yield force for the 6 
month SOST KO ML bones (Figure 3.48). There was an observed statistical difference 
between 12 month SOST KO mice and their WT littermates, regardless of bend direction 
(Figure 3.45). Interestingly, there was a significant difference in yield force between 6 
month SOST KO mice when the loading direction was ML or AP, which was found to be 
statistically equivalent to the AP and ML values for the WT littermates (Figure 3.44). 
 
Figure 3.34: Histogram displaying the comparison of yield force for 6 month old SOST 
Transgenic mice. WT 1 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.35: Histogram displaying the comparison of yield force for 6 month old SOST 
Transgenic mice. WT 2 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.36: Histogram displaying the comparison of yield force for 6 month old SOST 
Knockout mice. WT 3 mice were control littermates and faithfully express murine SOST. 
No animals were excluded from this analysis. 
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Figure 3.37: Histogram displaying the comparison of yield force for 12 month old SOST 
Knockout mice. WT 4 mice were control littermates and faithfully express murine SOST. 
No animals were excluded from this analysis. 
Figure 3.38: Histogram displaying the comparison of yield force for 6 month old mice. 
WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO respectively) 
and faithfully express murine SOST. No animals were excluded from this analysis. 
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Figure 3.39: Histogram displaying the comparison of yield force for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
Figure 3.40: Histogram displaying the comparison of yield force for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
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Figure 3.41: Histogram of the average values of yield force for all bones by bend 
direction. 
Figure 3.42: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 6 month old SOST Transgenic mice. WT 1 mice were control littermates 
and faithfully express murine SOST. No animals were excluded from this analysis. 
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Figure 3.43: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 8 month old SOST Transgenic mice. WT 2 mice were control littermates 
and faithfully express murine SOST. No animals were excluded from this analysis. 
Figure 3.44: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 6 month old SOST Knockout mice. WT 3 mice were control littermates and 
faithfully express murine SOST. No animals were excluded from this analysis. 
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Figure 3.45: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 12 month old SOST Knockout mice. WT 4 mice were control littermates 
and faithfully express murine SOST. No animals were excluded from this analysis. 
Figure 3.46: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 6 month old mice. WT 1 and 3 mice were control littermates (SOST 
TG/DEF and SOST KO respectively) and faithfully express murine SOST. No animals 
were excluded from this analysis. 
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Figure 3.47: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 6 month old Transgenic mice and 8 month old Transgenic mice. Wild type 
controls were not included in this analysis. 
Figure 3.48: Histogram displaying the comparison of yield force in the AP or ML bend 
direction for 6 month old Knockout mice and 12 month old Knockout mice. Wild type 
controls were not included in this analysis. 
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3.5 Ultimate Force 
Ultimate force was predicted to be significantly affected by both treatment type and bend 
direction. Bone formation differences between the treatment groups along with the 
difference in principle axis of loading between anterior-posterior (AP) and medial-lateral 
(ML) directions were the hypothesized reasons for this variation. The leg (left or right) 
was not predicted to have an influence on the outcome of the test. Three values had 
standardized residuals of greater than ±2.75 and were excluded from the analysis for 
normality. Figure 3.49 shows the associated p-values for the general linear model (GLM) 
analysis for this data set. Figure 3.50 displays the interaction between different treatment 
groups and bend direction along with associated means and significantly different 
groupings, as determined by a Tukey’s comparison with a 95% confidence interval. 
 
Figure 3.49: GLM of ultimate force across treatment groups and associated p-values. 
Data shown reflects statistical analysis and excludes 3 outlier values. 
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Figure 3.50: Treatment group averages and significantly different value groupings for 
ultimate force. Data shown reflects statistical analysis and excludes 3 outlier values. WT 
1-4 are control littermates of SOST TG 6 month, SOST TG 8 month, SOST KO 6 month, 
and SOST KO 12 month respectively. These mice faithfully express murine SOST. 
Individually, both treatment group (p = 0.00) and bend direction (p = 0.00) were 
determined to significantly affect the ultimate force. There was also a significant 
interaction between the combination of treatment group and bend direction (p = 0.002). 
Observations from these results show that there was no significant difference due to the 
interaction of treatment group and bend direction between 6 month old SOST TG, SOST 
DEF, and their control littermate (WT 1) mice (Figure 3.59). This observation was also 
true for the 8 month old SOST TG, DEF, and their control littermate (WT 2) mice (Figure 
3.60). There was also no significant difference between these two age groups (Figure 
3.64). The ultimate force for 6 and 12 month SOST KO bones tested in the ML direction 
were found to be statistically equivalent and the ultimate force for bones tested in the AP 
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direction for the same groups were also found to be statistically equivalent (Figure 3.65). 
In additional, all SOST KO mice were significantly different from their WT littermates 
(Figures 3.61 and 3.62). 
Figure 3.51: Histogram displaying the comparison of ultimate force for 6 month old 
SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.52: Histogram displaying the comparison of ultimate force for 6 month old 
SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.53: Histogram displaying the comparison of ultimate force for 6 month old 
SOST Knockout mice. WT 3 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.54: Histogram displaying the comparison of ultimate force for 12 month old 
SOST Knockout mice. WT 4 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.55: Histogram displaying the comparison of ultimate force for 6 month old 
mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
Figure 3.56: Histogram displaying the comparison of ultimate force for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
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Figure 3.57: Histogram displaying the comparison of ultimate force for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
 
Figure 3.58: Histogram of the average values of ultimate force for all bones by bend 
direction. 
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Figure 3.59: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old SOST Transgenic mice. WT 1 mice were control 
littermates and faithfully express murine SOST. No animals were excluded from this 
analysis. 
Figure 3.60: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 8 month old SOST Transgenic mice. WT 2 mice were control 
littermates and faithfully express murine SOST. No animals were excluded from this 
analysis. 
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Figure 3.61: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old SOST Knockout mice. WT 3 mice were control 
littermates and faithfully express murine SOST. No animals were excluded from this 
analysis. 
Figure 3.62: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old SOST Knockout mice. WT 4 mice were control 
littermates and faithfully express murine SOST. No animals were excluded from this 
analysis. 
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Figure 3.63: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old mice. WT 1 and 3 mice were control littermates (SOST 
TG/DEF and SOST KO respectively) and faithfully express murine SOST. No animals 
were excluded from this analysis. 
Figure 3.64: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old Transgenic mice and 8 month old Transgenic mice. Wild 
type controls were not included in this analysis. 
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Figure 3.65: Histogram displaying the comparison of ultimate force in the AP or ML 
bend direction for 6 month old Knockout mice and 12 month old Knockout mice. Wild 
type controls were not included in this analysis. 
3.6 Post-Yield Displacement 
Post-yield displacement was predicted to be significantly affected by both treatment type 
and bend direction. Bone formation differences between the treatment groups along with 
the difference in principle axis of loading between anterior-posterior and medial-lateral 
were the hypothesized reasons for this variation. The leg (left or right) was not predicted 
to have an influence on the outcome of the test. One value had a standardized residual of 
greater than ±2.75 and was excluded from the analysis for normality. Figure 3.66 shows 
the associated p-values for the general linear model (GLM) analysis for this data set. 
Figure 3.67 displays the interaction between different treatment groups and bend 
direction along with associated means and significantly different groupings, as 
determined by a Tukey’s comparison with a 95% confidence interval. 
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Figure 3.66: GLM of post-yield displacement across treatment groups and associated p-
values. Data shown reflects statistical analysis and excludes 1 outlier value. 
 
Figure 3.67: Treatment group averages and significantly different value groupings for 
post-yield displacement. Data shown reflects statistical analysis and excludes 1 outlier 
value. WT 1-4 are control littermates of SOST TG 6 month, SOST TG 8 month, SOST 
KO 6 month, and SOST KO 12 month respectively. These mice faithfully express murine 
SOST. 
There were no factors which significantly affected the post-yield displacement. Post-yield 
behavior for all treatment groups and bend directions were considered statistically 
equivalent. There was no significant interaction between treatment group and bend 
direction. 
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Figure 3.68: Histogram displaying the comparison of post yield displacement for 6 month 
old SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.69: Histogram displaying the comparison of post yield displacement for 6 month 
old SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.70: Histogram displaying the comparison of post yield displacement for 6 month 
old SOST Knockout mice. WT 3 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.71: Histogram displaying the comparison of post yield displacement for 12 
month old SOST Knockout mice. WT 4 mice were control littermates and faithfully 
express murine SOST. No animals were excluded from this analysis. 
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Figure 3.72: Histogram displaying the comparison of post yield displacement for 6 month 
old mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
 
Figure 3.73: Histogram displaying the comparison of post yield displacement for 6 month 
old Transgenic mice and 8 month old Transgenic mice. Wild type controls were not 
included in this analysis. 
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Figure 3.74: Histogram displaying the comparison of post yield displacement for 6 month 
old Knockout mice and 12 month old Knockout mice. Wild type controls were not 
included in this analysis. 
3.7 Yield Stress 
Yield stress was predicted to be significantly affected by both treatment type and bend 
direction. Bone formation differences between the treatment groups along with the 
difference in principle axis of loading between anterior-posterior (AP) and medial-lateral 
(ML) directions were the hypothesized reasons for this variation. The leg (left or right) 
was not predicted to have an influence on the outcome of the test. Figure 3.75 shows the 
associated p-values for the general linear model (GLM) analysis for this data set. Figure 
3.76 displays the interaction between different treatment groups and bend direction along 
with associated means and significantly different groupings, as determined by a Tukey’s 
comparison with a 95% confidence interval. 
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Figure 3.75: GLM of yield stress across treatment groups and associated p-values. There 
were no outliers in the data set. 
 
Figure 3.76: Treatment group averages and significantly different value groupings for 
yield stress. There were no outliers in the data set. WT 1-4 are control littermates of 
SOST TG 6 month, SOST TG 8 month, SOST KO 6 month, and SOST KO 12 month 
respectively. These mice faithfully express murine SOST. 
 
There were no factors which significantly affected the yield stress. The interaction of 
treatment group and bend direction was also found to not significantly affect the yield 
stress. The yield stresses for all treatment groups and bend directions were considered 
statistically equivalent. 
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Figure 3.77: Histogram displaying the comparison of yield stress for 6 month old SOST 
Transgenic mice. WT 1 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.78: Histogram displaying the comparison of yield stress for 6 month old SOST 
Transgenic mice. WT 2 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.79: Histogram displaying the comparison of yield stress for 6 month old SOST 
Transgenic mice. WT 3 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
Figure 3.80: Histogram displaying the comparison of yield stress for 12 month old SOST 
Transgenic mice. WT 4 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.81: Histogram displaying the comparison of yield stress for 6 month old mice. 
WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO respectively) 
and faithfully express murine SOST. No animals were excluded from this analysis. 
Figure 3.82: Histogram displaying the comparison of yield stress for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
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Figure 3.83: Histogram displaying the comparison of yield stress for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
3.8 Ultimate Stress 
Ultimate stress was predicted to be significantly affected by both treatment type and bend 
direction. Bone formation differences between the treatment groups along with the 
difference in principle axis of loading between anterior-posterior (AP) and medial-lateral 
(ML) directions were the hypothesized reasons for this variation. The leg (left or right) 
was not predicted to have an influence on the outcome of the test. Figure 3.84 shows the 
associated p-values for the general linear model (GLM) analysis for this data set. Figure 
3.85 displays the interaction between different treatment groups and bend direction along 
with associated means and significantly different groupings, as determined by a Tukey’s 
comparison with a 95% confidence interval. 
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Figure 3.84: GLM of ultimate stress across treatment groups and associated p-values. 
There were no outliers in the data set. 
 
Figure 3.85: Treatment group averages and significantly different value groupings for 
ultimate stress. There were no outliers in the data set. WT 1-4 are control littermates of 
SOST TG 6 month, SOST TG 8 month, SOST KO 6 month, and SOST KO 12 month 
respectively. These mice faithfully express murine SOST. 
 
There were no factors which significantly affected the ultimate stress, although treatment 
group was marginally significant. The interaction of treatment group and bend direction 
was also found to not significantly affect the ultimate stress. The ultimate stresses for all 
treatment groups and bend directions were considered statistically equivalent.  
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Figure 3.86: Histogram displaying the comparison of ultimate stress for 6 month old 
SOST Transgenic mice. WT 1 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
Figure 3.87: Histogram displaying the comparison of ultimate stress for 6 month old 
SOST Transgenic mice. WT 2 mice were control littermates and faithfully express 
murine SOST. No animals were excluded from this analysis. 
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Figure 3.88: Histogram displaying the comparison of ultimate stress for 6 month old 
SOST Knockout mice. WT 3 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
 
Figure 3.89: Histogram displaying the comparison of ultimate stress for 12 month old 
SOST Knockout mice. WT 4 mice were control littermates and faithfully express murine 
SOST. No animals were excluded from this analysis. 
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Figure 3.90: Histogram displaying the comparison of ultimate stress for 6 month old 
mice. WT 1 and 3 mice were control littermates (SOST TG/DEF and SOST KO 
respectively) and faithfully express murine SOST. No animals were excluded from this 
analysis. 
Figure 3.91: Histogram displaying the comparison of ultimate stress for 6 month old 
Transgenic mice and 8 month old Transgenic mice. Wild type controls were not included 
in this analysis. 
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Figure 3.92: Histogram displaying the comparison of ultimate stress for 6 month old 
Knockout mice and 12 month old Knockout mice. Wild type controls were not included 
in this analysis. 
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IV. DISCUSSION 
The primary goal of this study was to identify biomechanical properties of bone resulting 
from expression of the SOST gene. Secondary goals were to test differences in bending 
strength between anterior-posterior (AP) and medial-lateral (ML) axes of loading along 
with potentially elucidating any difference in left and right limbs. Femurs from 
hybridized mice were obtained from Lawrence Livermore National Labs and tested using 
3-point bending until fracture. Force and displacement data were captured along with 
measured geometric data of the bones in order to calculate and analyze mechanical 
properties of bone. 
The hypothesis was that there would be a significant difference between bones which 
expressed SOST (TG) and those which had genomes devoid of the region coding for 
SOST expression (KO). Since SOST expression negatively regulates bone formation, it 
was anticipated that the KO mice would have larger geometric measurements along with 
an increased resistance to fracture due to additional bone formation caused by the 
absence of SOST. In addition, femurs tested in the ML direction were predicted to have a 
greater breaking force as this axis is the principle direction of loading under normal 
skeletal conditions. It was also anticipated that there would be no difference between left 
and right limbs, consistent with previous reports [9]. 
Outcomes were predicted to be useful for further evidence and validation of current bone 
property knowledge. Potential differences could provide supporting evidence for 
continued research into the mechanisms of action of SOST which may lead to strategic 
utilization of gene therapy to combat prevalent bone diseases including osteoporosis. 
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4.1 Analysis of Results 
4.1.1 Cross Sectional Area 
Results showed treatment group to be the only factor which significantly affected CSA (p 
< 0.001). The absence of side-to-side differences in limb cross sectional area for all mice 
was also observed (p = 0.448). In addition, no interaction was found between treatment 
group and the leg broken (p = 0.648). Bending direction was not analyzed for this 
geometric property, as cross-sectional area is independent of the direction the limbs are 
loaded during mechanical testing.  
Significant differences between the KO mice, their respective WT controls, and TG mice 
appeared to be closely related to SOST expression. It was found that 12 month old KO 
mice had the largest cross sectional area, which may have resulted from the increased 
amount of time for unregulated bone growth. Cross sectional area of 6 month old KO 
mice was found to be significantly less than 12 month KO along with being significantly 
greater than all WT and TG mice. This difference was also consistent with the absence of 
SOST which would lead to greater bone formation in comparison to the mice with 
regulated bone formation. Interestingly, DEF mice (a subset of TG mice expressing twice 
the amount of SOST as TG mice) did not have a significantly different cross sectional 
area than TG mice or their WT control littermates. In addition, there was no cross 
sectional area difference in the age groups (6 and 8 months old) of TG mice.  
These results validate the successful hybridization of mice, in such that mice with no 
SOST expression formed significantly more bone than those with SOST expression. The 
absence of a significant difference between TG, DEF, and WT mice suggests that SOST 
uptake is limited to the number of receptors available and not resultant of the total 
83 
 
amount of SOST transcription. In this situation, a gross overexpression of SOST may not 
directly result in reduced bone formation or bone growth regulation during skeletal 
maturation. Although this whole-bone assessment suggests that there is not a direct 
correlation between SOST overexpression and reduced cortical bone formation in 
comparison to normal levels of SOST, data from Loots et al. [39] have shown that 
trabecular bone may be much more significantly impacted by SOST overexpression.  
The lack of significance between left and right femora adds to the hypothesis that there is 
no systematic side-to-side difference in bone formation. The most interesting and 
potentially significant finding was the absence of difference in cross sectional area due to 
age of TG mice while there was an observed difference due to age in SOST KO mice. As 
mice of most strains typically reach skeletal maturity at 4-5 months old [78], this finding 
suggests an increase in bone formation following maturity resulting from the elimination 
of SOST. 
4.1.2 Area Moment of Inertia 
Results showed treatment group to be the only factor which significantly affected area 
moment of inertia (p < 0.001). Interestingly, there was a marginal effect on area moment 
of inertia due to the leg broken (p = 0.072). No interaction observed between treatment 
group and the leg broken (p = 0.494). For this calculated parameter, bending direction 
was not analyzed, as moment of inertia is independent of the direction the limbs are 
loaded during mechanical testing. 
It was anticipated that there would be a significant difference in area moment of inertia 
between treatment groups, however the marginal difference of left versus right limbs was 
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not predicted. Interesting observations included the absence of a difference between all 6 
and 8 month old TG mice (TG, DEF, and WT littermates), the absence of a difference 
between 6 month old KO mice and WT littermates, and the presence of a difference 
between 12 month old KO and WT mice. 
Larger calculated area moment of inertia values suggest an increase in the resistance to 
bending stress. KO mice were predicted to have the highest values due to added bone 
formation leading to fracture resistance. This prediction was observed as the KO mouse 
groups had the two highest area moment of inertia values. The marginal difference in 
side-to-side may have resulted from unequal sample sizes, as there were 49 right legs 
included in this analysis while there were only 47 left legs. The difference in values of 
0.5 and 0.4, respectively, is close enough to have been impacted by the difference in 
sample size, as the one excluded outlier was in the 12 month KO group which displayed 
the highest values of area moment of inertia.  
4.1.3 Elastic Modulus 
Both treatment group (p < 0.001) and bend direction (p < 0.001) were determined to 
significantly affect the calculated elastic modulus. There was no observed interaction 
between treatment group and the bend direction (p = 0.812). Leg was excluded from this 
analysis and bend direction was analyzed, as side-to-side differences were assumed to be 
negligible in respect to resistance to elastic deformation. 
It was anticipated that the SOST KO mice would have increased resistance to elastic 
deformation due to the increased bone accumulation. In addition, since more bone is 
formed in the ML regions of the femoral diaphysis, where there are increased stresses, it 
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was also anticipated that bones broken in the ML direction would yield a higher modulus. 
Interesting observations included the absence of a difference in elastic modulus between 
all 6 and 8 month old TG mice (TG, DEF, and WT littermates) along with no difference 
between 6 and 12 month KO mice and their respective WT littermates. Also, contrary to 
the expected results, it was found that bones broken in the AP direction were significantly 
more resistant to elastic deformation than bones in the ML direction. 
The elastic modulus was calculated from the slope of the stress-strain curve using a 
0.02% offset. It was found that the elastic modulus was higher in all TG mice in 
comparison to the KO mice. This observation was unusual when combined with the 
hypothesis that increased bone formation would allow for greater elastic resistance to 
applied force. Potentially, the additional bone formation resulted in the ability for KO 
bones to resist fracture while experiencing increased microfracture damage due to applied 
loads. This observation may correlate with the difference seen in the AP and ML bend 
directions, as additional bone in the ML regions may allow for increased damage prior to 
fracture rather than a greater resistance to deformation. 
 4.1.4 Yield Force 
Individually, both treatment group (p < 0.001) and bend direction (p < 0.001) were 
determined to significantly affect yield force. There was also a significant interaction 
between the combination of treatment group and bend direction (p < 0.001). Bend 
direction was included in this analysis, as side-to-side differences were assumed to be 
negligible in respect to resistance to yield force. 
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The unregulated bone growth in KO mice was predicted to have a significant effect on 
the amount of force the bone could withstand prior to yield. Consistent with this 
hypothesis, bones broken in the ML direction were expected to behave the same way in 
comparison to those broken in the AP direction. Important observations included the 
similarity of 12 month KO bones broken in the AP and ML directions along with the 
observed difference of 6 month KO bones in these directions. All bones broken for both 6 
month and 8 month TG mice were found to be statistically equivalent. Lastly, bones 
broken in the ML direction were found to have a significantly higher yield force than 
those in the AP direction. 
As expected, bones broken in the ML direction for the 6 month and 12 month KO bones 
were found to give the highest value for yield force. The additional bone formed due to 
the absence of SOST is predicted to be the driving factor behind the high yield force 
observations. The most interesting and unpredicted observation was the low yield force 
value for the 6 month KO bones broken in the AP direction, which was not found to be 
different from values of the TG mice and WT littermates. Overall, the high yield force of 
bones broken in the ML direction confirmed the hypothesis and is also assumed to be 
attributed to the increased bone formation in these regions. 
4.1.5 Ultimate Force 
As with yield force, both treatment group (p < 0.001) and bend direction (p < 0.001) were 
determined to individually affect ultimate force. There was also a significant interaction 
between the combination of treatment group and bend direction (p = 0.002). Bend 
direction was included in this analysis, as side-to-side differences were assumed to be 
negligible in respect to resistance to ultimate force. 
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Observed results were consistent with the overall hypotheses that KO mice would display 
the highest values for ultimate force as well as bones broken in the ML direction having 
larger values than bones broken in the AP direction. Consistent with the yield force 
observation, 6 month KO bones broken in the ML direction gave the highest values for 
ultimate force and were statistically equivalent to values of the 12 month KO ML bones. 
The hypothesis was supported as 6 and 12 month KO bones broken in the ML direction 
were found to be statistically equivalent to each other and significantly different from 
corresponding treatment group bones broken in the AP direction. The KO bones were 
also significantly different from all TG and WT mice, independent of bend direction. 
There was no observed difference between 6 and 8 month TG mice.  
These results are mostly consistent with the yield force results for the corresponding 
treatment groups. The added bone in both KO mice as well as in the ML direction is 
assumed to be the cause of the increased resistance to overall fracture. These results may 
provide a better assessment of whole bone fracture properties in comparison to yield 
force, as they tend to be in line with the overall assumption that increased bone mass will 
result in increased resistance to fracture.  
4.1.6 Post Yield Displacement 
Results showed that there were no factors which significantly affected the post-yield 
displacement. No significant difference was detected for treatment groups (p = 0.416) and 
bend directions (p = 0.551). There was no significant interaction between treatment group 
and bend direction (p = 0.349). 
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These observations did not support the hypothesis that each of the factors (treatment 
group and bend direction) would have some significant effect on the post yield 
displacement. Considering that the elastic modulus was found to be dependent on the 
treatment group, the finding that there was no difference between treatment groups is 
surprising. It was assumed that an increase in resistance to elastic deformation would 
correlate with bones being more brittle and thus a reduction in the displacement between 
yield and fracture. In addition, bend direction was assumed to impact the post yield 
behavior of bone due to the increased amount of bone in the ML direction and thus the 
potential ability to withstand fracture following damage. 
4.1.7 Yield Stress 
There were no factors which significantly affected the yield stress, with all treatment 
groups (p = 0.757) and bend directions (p = 0.836) showing no difference. There was no 
significant interaction between treatment group and bend direction (p = 0.640). 
These observations did not support the hypothesis that each of the factors (treatment 
group and bend direction) would have some significant effect on the yield stress. 
Considering that the area moment of inertia was found to be dependent on the treatment 
group, the finding that there was no difference between treatment groups is surprising. It 
was assumed that the larger values for area moment of inertia would correspond to the 
lowest stress values. This prediction was inconsistent with the observed results. There 
may have been significant error in the yield stress data due to unequal sample sizes or the 
low number of samples in some treatment groups.  
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4.1.8 Ultimate Stress 
There were no factors which significantly affected the ultimate stress, however the 
treatment groups were shown to have a marginally significant effect (p = 0.054). There 
was no difference in bend direction (p = 0.214) and there was no significant interaction 
between treatment group and bend direction (p = 0.726). 
These observed results did not support the hypothesis that each of the factors (treatment 
group and bend direction) would have significant effect on the ultimate stress. Concurrent 
with the assumption for yield stress, the finding that area moment of inertia was 
dependent on the treatment group results in the surprising observation of no difference 
between treatment groups for ultimate stress. It was again assumed that the larger values 
for area moment of inertia would correspond to the lowest stress values. Although the 
results are marginally significant, this assumption proved to be incorrect in comparison to 
the results from the two parameters. There may have been significant error in the yield 
stress data due to the large difference in sample sizes or the low number of samples in 
some treatment groups.  
4.2 Challenges/Limitations 
There were a few challenges/limitations experienced during the conduct of this study. 
Most importantly, there were small and unequal sample sizes for the different treatment 
groups, including varying numbers of male and female mice in each group. These 
inequalities may have resulted in non-significant differences between some of the 
treatment groups. When conducting statistical comparisons the lack of repetition, caused 
by small sample sizes within some treatment groups, made it necessary to run the general 
linear model (GLM) with only 2 factors (Treatment Group and either Leg or Bend 
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Direction). Had there been repetition within all of the groups, the analysis could have 
been conducted with all three factors allowing for a more in depth analysis of the effect 
that each factor had on the others. If all three factors were included in the analysis the 
randomization used would have been inadequate. Minitab was used to randomize all 50 
left legs to either the AP or ML bend direction (25 each direction) and the right leg was 
broken in the opposite direction. In order to have obtained truly equal sample sizes, this 
randomization would have needed to be conducted on a per treatment group basis rather 
than on the entire sample set.  
When conducting the 3-point bend test, it was often difficult to keep bones broken in the 
ML direction in place. Clay was used to help secure these bones in the proper orientation, 
although there were instances when this was not sufficient. On a few occasions the bone 
was contacted by the probe and at some point during the test it would slip from the 
intended orientation. This would typically occur at a time where plastic deformation had 
occurred, thus rendering the bone unable to be retested, and as such the test was 
completed with the bone out of its initial orientation. This is expected to have had some 
effect on the non-observance of differences in AP versus ML bend directions for some of 
the parameters. 
Measuring of geometric data at the fracture site was conducted under a microscope with 
the use of a crosshair reticle and a moveable stage controlled by micromanipulators. This 
process was used, rather than Image J analysis, due to limitations of the microscope and 
camera combination. Using the available equipment, the magnification was too large and 
as such it was not possible to take a single image of the entire bone at the fracture site. 
Had this been possible, potentially more accurate measurements would have been made 
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using the Image J software for the cross sectional area of the bones. One possible 
advantage of measuring the geometric data using the microscope was that bones were 
often broken in an oblique fracture, which may not have allowed for clear capturing of an 
image at the fracture site. The microscope often required refocusing to allow for clear 
identification of the edge of the major axis as the stage was moved from anterior to 
posterior or medial to lateral regions. Both possible measurement techniques have 
advantages and disadvantages which may result in slightly different results. 
Lastly, in calculating many of the parameters, generalizations were made when writing 
the Matlab code. This was done to allow for calculation of multiple bone samples rather 
than individually identifying and calculating each parameter by hand. These 
generalizations combined with the previously mentioned difficulty of maintaining bones 
in their intended orientation during testing may have led to inaccurate force-displacement 
curves and thus inaccurate results for the calculated parameters. 
4.3 Significance of Results 
Comparison of data obtained from this study with that of a previous 3-point bend study 
reported by Wergedal et al [79] showed similar results for many biomechanical 
properties. Wergedal et al [79] performed 3-point bending tests on 29 different strains of 
inbred mice, including 3 different genetic variations of C57 mice. The following table 
shows the comparison of the average of the 29 mouse strains analyzed by Wergetal et al 
[79] and the different treatment groups in this study.  
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Table 2: Comparison of findings from this study to those of Wergedal et al 2009 [79]. 
Treatment Group CSA (mm^2) 
Ixx 
(mm^4) 
E 
(GPa) 
Ultimate Force 
(N) 
Ultimate Stress 
(MPa) 
SOST TG 6 month 0.88 0.216 2.84 11.4 98.7 
WT 1  1.04 0.219 5.04 18.6 169 
SOST DEF 6 month 0.94 0.183 6.17 14.4 155 
SOST TG 8 month 0.9 0.194 4.82 13.8 140 
WT 2 1.03 0.285 5.43 13.3 116 
SOST DEF 8 month 0.84 0.172 6.2 13.2 147 
SOST KO 6 month 2.86 0.822 1.32 57.5 175 
WT 3 1.71 0.56 2.09 30.1 140 
SOST KO 12 month 3.95 1.89 1.64 64.6 135 
WT 4 1.32 0.394 4.61 25.5 166 
Wergedal et al 2009 1.47 0.134 6.56 18.7 176 
 
Although there may have been calculation errors due to geometric measuring and 
computer analysis, many of the large differences in values shown above are consistent 
with the hypothesis that the enhanced bone formation due to removal of the SOST gene 
increases cross sectional area, yield force, and ultimate force. There may have been 
significant error in the calculation of the area moment of inertia, modulus, and stress 
values, although the differences seen may accurately reflect the impact SOST has on 
bone properties. Further analysis and computation of calculated values (area moment of 
inertia, elastic modulus, post yield displacement, yield stress, ultimate stress) by hand 
may be useful in determining the overall validity of the findings of this study. 
4.4 Future Work 
The work completed in this study was done to assess the whole-bone biomechanical 
properties of murine femurs which either did or did not express the SOST gene. Further 
analysis of the resulting fracture site can be performed to enhance understanding of the 
effect SOST has on bone formation. 
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4.4.1 Imaging 
Imaging of the fracture site, resulting from 3-point bending, would allow for additional 
analysis and comparison of treatment groups. Potential imaging with a scanning electron 
microscope (SEM) may provide insight into the different bone structural units and 
characterization of bone integrity in the various treatment groups. This information may 
be useful in understanding the bone modeling and remodeling effect that the SOST gene 
has on bone. In addition, imaging using polarized light could allow for identification of 
differences in collagen fiber orientation which may be altered due to the expression of 
SOST. Collagen fiber orientation has previously been thought to be an important 
predictor of bone strength [80-81]. 
4.4.2 Nanoindentation 
Nanoindentation has been applied in recent years to measure elastic properties of bone 
tissue at a microscopic length scale, overcoming the limitations of traditional mechanical 
testing techniques for small samples [82-84]. This method is precise and accurate [85] 
and appears well suited for measuring material properties in mouse bones [73]. 
Nanoindentation provides a measure of the modulus of the solid phase of bone at the 
microstructural scale, with no influence of porosity (where porosity includes vascular and 
resorption but not lacunar or canicular voids) [11]. 
Samples which have previously undergone 3-point bending can be embedded and used 
for nanoindentation testing to obtain a more complete representation of mechanical 
properties of cortical bone. Samples are typically dehydrated in ethanol, embedded in 
poly(methyl methacrylate) (PMMA) [73, 85-86], and polished to a mirrored surface. 
Once these preparation steps are completed, nanoindentation can be conducted. 
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4.4 Conclusions 
Identification of significant differences in biomechanical properties of bones from mice 
that express the SOST gene and those that do not can help advance the understanding of 
how SOST works and determine if it is a suitable target for applied gene therapy. The 
findings of this study show that mice hybridized by Lawrence Livermore National Labs 
that do not express SOST have significantly more bone formation and some enhanced 
biomechanical properties in comparison to littermate controls and transgenic mice. 
Further analysis of these bones needs to be conducted in order to generate an accurate 
picture of the overall impact of SOST on bone formation. If the structural integrity and 
quality of bone resulting from the removal of the SOST gene is shown to be comparable 
to that of normal, healthy bone, the use of gene therapy to combat diseases/disorders such 
as osteoporosis may lead to important medical breakthroughs in and has the potential to 
impact millions of individuals. 
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APPENDIX A: Mouse Treatment Groups and Data Values 
SOST TG, 8 months 
#  Sex  Treatment 
5588  F  DEF 
5589  F  DEF 
8007  F  DEF 
8008  F  DEF 
5592  F  TG 
5599  F  TG 
5590  F  WT 
5593  F  WT 
5597  F  WT 
5598  F  WT 
 
 
 
SOST KO, 12 months 
#  Sex  Treatment 
7544  M  KO 
7565  M  KO 
7592  M  KO 
7593  M  KO 
7594  M  KO 
7545  M  WT 
7564  M  WT 
 
SOST TG, 6 months 
#  Sex  Treatment
8587  M  DEF 
8601  M  DEF 
8641  M  DEF 
8642  M  DEF 
8658  M  DEF 
9294  F  DEF 
9295  F  DEF 
9528  F  DEF 
9530  F  DEF 
9293  F  TG 
9296  F  TG 
8599  M  WT 
8600  M  WT 
8640  M  WT 
8656  M  WT 
8657  M  WT 
8602  F  WT 
8603  F  WT 
8643  F  WT 
9526  F  WT 
9527  F  WT 
9529  F  WT 
SOST KO, 6 months 
#  Sex  Treatment 
9198  M  KO 
9200  M  KO 
9201  M  KO 
9202  M  KO 
9203  M  KO 
9207  M  WT 
9208  M  WT 
9209  M  WT 
9238  M  WT 
9239  M  WT 
9240  M  WT 
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APPENDIX B: Matlab Code 
clear 
 
%choose manual input of bone geometries or entry from .csv file 
prompt = {'Manual entry (enter "0") or Entry from .csv file (enter "1"):'}; 
dlg_title = 'Bone Geometry Dimensions'; 
num_lines = 1; 
def = {'1'}; 
answer = inputdlg(prompt,dlg_title,num_lines,def); 
 
man_auto = str2num(answer{1}); %state: manual = 0, automatic = 1 
 
%request path (to save outputs) from user 
path = uigetdir('','Choose or create a location to save outputs:'); 
 
%create data file for outputs 
datafile = uiputfile('*.csv', 'Save output data file as:', 'datafile.csv'); 
fid = fopen(datafile, 'a'); 
labels = {'Bone Name:' 'Bending Direction:' 'Cross-sectional Area (mm^2):' 'Eobs (GPa):' 
'Yield Load (N):' 'Ultimate Load (N):' 'Post Yield Displacement (mm):' 'Yield Stress 
(MPa):' 'Ultimate Stress (MPa):' 'R^2:'}; 
for n = 1:size(labels) 
    fprintf(fid,'%s,',labels{n,1:end-1}); 
    fprintf(fid,'%s\n',labels{n,end}); 
end 
fclose(fid); 
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if man_auto == 0 
    %request directory location from user 
    [PathName] = uigetdir('','Select directory of data files for analysis:'); 
 
    %load data files 
    allfiles = dir([PathName, '\*.FIB']); 
     
end 
     
if man_auto == 1 
    %request directory location from user 
    [PathName] = uigetdir('','Select directory of data files for analysis:'); 
 
    %load data files 
    allfiles = dir([PathName, '\*.FIB']); 
     
    %request bone geometry file location from user 
    [FileName_geo,PathName_geo] = uigetfile('*.*','Select file containing bone geometry 
data'); 
     
    %load bone geometry data file 
    fid=fopen([PathName_geo,FileName_geo]); 
    bonedata = textscan(fid,'%s %s %s %f %f %f %f %f 
%f','HeaderLines',1,'Delimiter',',','CollectOutput',1); 
    fclose(fid); 
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    %create name matching array 
    for i = 1:length(bonedata{1,1}) 
        matchname(i,1) = strcat(bonedata{1,1}(i,1), bonedata{1,1}(i,2));  
    end 
     
end 
 
    %open waitbar 
    wait = waitbar(0,'Please Wait...','Name','Generating 
Plots...','CreateCancelBtn','setappdata(gcbf,''canceling'',1)'); 
    setappdata(wait,'canceling',0) 
 
for e = 1:length(allfiles) 
     
    %stop calculations if 'Canel' is clicked on waitbar 
    if getappdata(wait,'canceling') 
        break 
    end 
     
    waitbar(e/length(allfiles),wait) 
     
    %clear working variables 
    clear F M cx cy fdx fdy maxind maxval regx regy strain stress x yfit yresid indval; 
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    FileName = allfiles(e).name; 
    file = csvread([PathName, '\', FileName]); 
     
    %remove extension from filename 
    FileName = strrep(FileName,'.FIB',''); 
 
    %establish arrays 
    x = zeros(size(file(),1),1); %displacement 
    F = zeros(size(file(),1),1); %force 
    M = zeros(size(file(),1),1); %bending moment 
    stress = zeros(size(file(),1),1); %stress 
    strain = zeros(size(file(),1),1); %strain 
    avg = zeros(size(file(),1),1); %average difference in stress 
 
    %populate arrays 
    for n = 1:size(file(),1) 
        x(n,1) = file(n,1); 
        F(n,1) = file(n,2); 
    end  
 
    %unit conversion 
    x = x*(1E-3); %um to mm 
    F = F*(1E-3); %mN to N 
 
    comp = 0; 
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    if man_auto == 1 
        for i = 1:length(bonedata{1,1}) 
            if strcmp(matchname(i,1), FileName) == 1 
                L = bonedata{1,2}(i,2); %bone length 
                APi = bonedata{1,2}(i,6); %anterior-posterior inner diameter 
                APo = bonedata{1,2}(i,5); %anterior-posterior outer diameter 
                MLi = bonedata{1,2}(i,4); %medial-lateral inner diameter 
                MLo = bonedata{1,2}(i,3); %medial-lateral outer diameter 
                d = bonedata{1,2}(i,1); %distance between supports 
                
                %warn user if inner/outer dimensions are reversed 
                if APi > APo 
                    errordlg('Inner AP dimension must be less than outer AP dimension. Check 
values in "bone measurements" data file.', 'AP Size Error'); 
                    error('Inner AP dimension must be less than outer AP dimension. Check 
values in "bone measurements" data file.'); 
                end 
                if MLi > MLo 
                    errordlg('Inner ML dimension must be less than outer ML dimension. Check 
values in "bone measurements" data file.', 'ML Size Error'); 
                    error('Inner ML dimension must be less than outer ML dimension. Check 
values in "bone measurements" data file.'); 
                end 
                 
                AP_ML_state = strcmp(bonedata{1,1}(i,3), 'ML'); 
                 
                comp = 1; 
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            elseif strcmp(matchname(i,1), FileName) == 0 && i == length(bonedata{1,1}) 
&& comp == 0                
                %request measured geometry values from user 
                prompt = {'Length (mm):','AP inner diameter (mm):','AP outer 
diameter(mm):','ML inner diameter (mm):','ML outer diameter (mm):','Distance between 
supports (mm):'}; 
                dlg_title = [FileName, ' -- Geometry']; 
                num_lines = 1; 
                def = {'','','','','',''}; 
                answer = inputdlg(prompt,dlg_title,num_lines,def); 
 
                L = str2num(answer{1}); %bone length 
                APi = str2num(answer{2}); %anterior-posterior inner diameter 
                APo = str2num(answer{3}); %anterior-posterior outer diameter 
                MLi = str2num(answer{4}); %medial-lateral inner diameter 
                MLo = str2num(answer{5}); %medial-lateral outer diameter 
                d = str2num(answer{1}); %distance between supports 
 
                %warn user if inner/outer dimensions are reversed 
                if APi > APo 
                    errordlg('Inner AP dimension must be less than outer AP dimension', 'AP 
Size Error'); 
                    error('Inner AP dimension must be less than outer AP dimension'); 
                end 
                if MLi > MLo 
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                    errordlg('Inner ML dimension must be less than outer ML dimension', 'ML 
Size Error'); 
                    error('Inner ML dimension must be less than outer ML dimension'); 
                end 
 
                %request bending direction from user 
                prompt = {'Anterior-Posterior (enter "0") or Medial-Lateral (enter "1"):'}; 
                dlg_title = [FileName, ' -- Bending Direction']; 
                num_lines = 1; 
                def = {'0'}; 
                answer = inputdlg(prompt,dlg_title,num_lines,def); 
 
                AP_ML_state = str2num(answer{1}); %state: 0 for AP, 1 for ML                 
                 
            end 
        end 
                         
    else 
        %request measured geometry values from user 
        prompt = {'Length (mm):','AP inner diameter (mm):','AP outer diameter(mm):','ML 
inner diameter (mm):','ML outer diameter (mm):','Distance between supports (mm):'}; 
        dlg_title = [FileName, ' -- Geometry']; 
        num_lines = 1; 
        def = {'','','','','',''}; 
        answer = inputdlg(prompt,dlg_title,num_lines,def); 
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        L = str2num(answer{1}); %bone length 
        APi = str2num(answer{2}); %anterior-posterior inner diameter 
        APo = str2num(answer{3}); %anterior-posterior outer diameter 
        MLi = str2num(answer{4}); %medial-lateral inner diameter 
        MLo = str2num(answer{5}); %medial-lateral outer diameter 
        d = str2num(answer{1}); %distance between supports 
         
        %warn user if inner/outer dimensions are reversed 
        if APi > APo 
            errordlg('Inner AP dimension must be less than outer AP dimension', 'AP Size 
Error'); 
            error('Inner AP dimension must be less than outer AP dimension'); 
        end 
        if MLi > MLo 
            errordlg('Inner ML dimension must be less than outer ML dimension', 'ML Size 
Error'); 
            error('Inner ML dimension must be less than outer ML dimension'); 
        end 
         
         
        %request bending direction from user 
        prompt = {'Anterior-Posterior (enter "0") or Medial-Lateral (enter "1"):'}; 
        dlg_title = [FileName, ' -- Bending Direction']; 
        num_lines = 1; 
        def = {'0'}; 
        answer = inputdlg(prompt,dlg_title,num_lines,def); 
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        AP_ML_state = str2num(answer{1}); %state: 0 for AP, 1 for ML 
         
    end 
 
    %calculate cross-sectional area of bone 
    A = (pi/4)*((APo*MLo)-(APi*MLi)); 
 
    %calculate area moment of inertia 
    if AP_ML_state == 0 
        Ixx = (pi/64)*((MLo*(APo^3))-(MLi*(APi^3))); %anterior-posterior 
    else 
        Ixx = (pi/64)*((APo*(MLo^3))-(APi*(MLi^3))); %medial-lateral 
    end 
 
    %calculate bending moment 
    for n = 1:size(file(),1) 
        M(n,1) = F(n,1)*(d/4); 
    End 
 
    %calculate bending stress (in units of MPa) and strain for each data point  
    if AP_ML_state == 0 
        for n = 1:size(file(),1) 
            stress(n,1) = ((M(n,1)*(APo/2))/Ixx); %also convert GPa to MPa 
            strain(n,1) = (12*x(n,1)*(APo/2))/(d^2); 
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        end 
    else 
       for n = 1:size(file(),1) 
        stress(n,1) = ((M(n,1)*(MLo/2))/Ixx); 
        strain(n,1) = (12*x(n,1)*(MLo/2))/(d^2); 
        end   
    end 
 
    %remove irrelevent data 
    cy(1,1) = 0; 
    cx(1,1) = 0; 
    fdy(1,1) = 0; 
    fdx(1,1) = 0; 
    
    for n = 1:size(file(),1)-1 
        if strain(n+1,1)-strain(n,1) > 0 
           cy(n+1,1) = stress(n,1); 
           cx(n+1,1) = strain(n,1); 
        end 
        if x(n+1,1)-x(n,1) > 0 
           fdy(n+1,1) = F(n,1); 
           fdx(n+1,1) = x(n,1); 
        end 
    end 
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    n = 1; 
    k = 0; 
    while k ~= 1 
        if cy(n,1)-cy(n+1,1) > (0.5)*mean(cy())  %if the difference between adjacent y 
values is greater than half of the current average 
            
            cy = cy(1:n+3,1); 
            cx = cx(1:n+3,1); 
            fdy = fdy(1:n+3,1); 
            fdx = fdx(1:n+3,1); 
            
            k = 1;  
        end 
        n = n+1; 
    end 
 
    %determine ultimate tensile strength 
    UTS = cy(1,1); 
    for n = 1:size(cy(),1) 
        if cy(n,1) > UTS 
            UTS = cy(n,1); 
            indval(1,1) = n; 
        end 
    end 
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    %linear regression to determine elastic modulus and yield strength 
    n = 50;             %start at point 50 to start with 'established' R^2 value 
    k = 0; 
    while  n < size(cy(),1) && k == 0 
        regx = zeros(n,1); 
        regy = zeros(n,1); 
        for m = 1:n 
            regx(m,1) = cx(m,1); 
            regy(m,1) = cy(m,1); 
        end 
        reg = regx\regy; 
        yfit = polyval([reg,0],regx); 
        yresid = regy - yfit; 
        SSresid = sum(yresid.^2); 
        SStotal = (length(regy)-1)*var(regy); 
        rsq(n,1) = 1 - (SSresid/SStotal); 
         
        if rsq(n,1) < rsq(n-1,1) && rsq(n,1) > 0.4 %if the current R^2 value is less than the 
previous one, and greater than 0.4 exit the loop -- it's not necessary to re-calculate 
            k = 1; 
            rsq_ind = n; 
        end 
         
        n = n+1; 
    end 
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        %calculate yield strength using 0.2% offset method 
        n = 50; 
        k = 0; 
        while n <= size(cx(),1) && k == 0 
            if cy(n,1) > 0.93*reg*(cx(n,1) - 0.002) && cy(n,1) < 1.07*reg*(cx(n,1) - 0.002); 
                YS = cy(n,1); 
                indval(2,1) = n; 
                k = 1; 
            elseif n == size(cx(),1) 
                YS = cy(n-3,1); 
                indval(2,1) = n - 3; %so that yield isn't 0 
            end 
            n = n+1; 
        end 
    
        Eobs = reg/1000; %observed elastic modulus (GPa) 
        Eobsx(1,1) = 0; 
        Eobsy(1,1) = 0; 
        Eobsx(2,1) = cx(rsq_ind); 
        Eobsy(2,1) = reg*Eobsx(2,1); 
 
    %other values to display 
    yl = fdy(indval(2,1),1); %yield load (N) 
    ul = fdy(indval(1,1),1); %ultimate load (N) 
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    pyd = fdx(end-3,1) - fdx(indval(2,1),1); %post yield displacement (mm) 
 
    %plot force vs. displacement 
    figure('visible','off'); %suppress graphics output 
    p1 = plot (fdx,fdy); 
    xlabel('Displacement (mm)') 
    ylabel('Force (N)') 
    title(['Force vs. Displacement, Bone ' FileName]) 
    set(p1,'Color','red','LineWidth',2) %change the line color and set its width to 2] 
    print('-dbmp','-r150',[path,'\',FileName,'_FD']); %save figure to output file 
 
    %plot stress vs. strain 
    figure('visible','off'); 
    p2 = plot 
(cx,cy,Eobsx,Eobsy,cx(indval(2,1)),cy(indval(2,1)),'^',cx(indval(1,1)),cy(indval(1,1)),'v'); 
    xlabel('Strain (mm/mm)') 
    ylabel('Stress (MPa)') 
    title(['Stress vs. Strain, Bone ' FileName]) 
    set(p2,'LineWidth',2) %set width to 2 
    print('-dbmp','-r150',[path,'\',FileName,'_SS']); 
    %print relevant calculated values to data file 
    fid = fopen(datafile, 'a'); 
%     fprintf(fid,'\r\n'); 
    if AP_ML_state == 0 
        AP_ML = 'AP'; 
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    else 
        AP_ML = 'ML'; 
    end 
    values = {FileName, AP_ML, A, Eobs, yl, ul, pyd, YS, UTS, Ixx, rsq(rsq_ind,1)}; 
    for n = 1:size(values) 
        fprintf(fid,'%s,',values{n,1:2}); 
        fprintf(fid,'%d,',values{n,3:end-1}); 
        fprintf(fid,'%d\n',values{n,end}); 
    end 
    fclose(fid); 
end 
 
delete(wait) 
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APPENDIX C: Minitab Statistical Outputs 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: CSA versus Genotype+Phenotype, Bend Direction, Leg  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
Leg                 fixed       2  L, R 
 
 
Analysis of Variance for CSA, using Adjusted SS for Tests 
 
                                    Model  Reduced 
Source                                 DF       DF     Seq SS 
Genotype+Phenotype                      9        9    93.7382 
Bend Direction                          1        1     0.3173 
Leg                                     1        1     0.1031 
Genotype+Phenotype*Bend Direction       9        9     0.4223 
Genotype+Phenotype*Leg                  9        6+    0.5387 
Bend Direction*Leg                      1        1     0.0034 
Genotype+Phenotype*Bend Direction*      9        6+    0.1800 
  Leg 
Error                                  57       63     7.7023 
Total                                  96       96   103.0053 
 
+ Rank deficiency due to empty cells, unbalanced nesting, collinearity, or an 
     undeclared covariate. No storage of results or further analysis will be 
     done. 
 
 
S = 0.349656   R-Sq = 92.52%   R-Sq(adj) = 88.61% 
 
  
Test for Equal Variances: CSA versus Genotype+Phenotype, Bend Direction, Leg  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction  Leg  N     Lower    StDev    Upper 
SOST KO 12 month KO         AP    L  2  0.244778  0.82015  811.434 
SOST KO 12 month KO         AP    R  3  0.344564  0.91960   32.376 
SOST KO 12 month KO         ML    L  3  0.468945  1.25155   44.063 
SOST KO 12 month KO         ML    R  2  0.004917  0.01647   16.300 
SOST KO 12 month WT         AP    L  2  0.111056  0.37210  368.149 
SOST KO 12 month WT         ML    R  2  0.092843  0.31108  307.772 
 SOST KO 6 month KO         AP    L  1         *        *        * 
 SOST KO 6 month KO         AP    R  3  0.087430  0.23334    8.215 
 SOST KO 6 month KO         ML    L  3  0.089483  0.23882    8.408 
 SOST KO 6 month KO         ML    R  1         *        *        * 
 SOST KO 6 month WT         AP    L  2  0.067568  0.22639  223.987 
 SOST KO 6 month WT         AP    R  4  0.183775  0.43387    5.181 
 SOST KO 6 month WT         ML    L  4  0.057620  0.13603    1.624 
 SOST KO 6 month WT         ML    R  2  0.006890  0.02309   22.841 
SOST TG 6 month DEF         AP    L  3  0.056994  0.15211    5.355 
SOST TG 6 month DEF         AP    R  6  0.070939  0.14542    0.741 
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SOST TG 6 month DEF         ML    L  6  0.088371  0.18115    0.923 
SOST TG 6 month DEF         ML    R  3  0.048725  0.13004    4.578 
 SOST TG 6 month TG         AP    L  2  0.004430  0.01484   14.684 
 SOST TG 6 month TG         ML    R  2  0.008237  0.02760   27.305 
 SOST TG 6 month WT         AP    L  7  0.095057  0.18599    0.766 
 SOST TG 6 month WT         AP    R  4  0.042941  0.10138    1.211 
 SOST TG 6 month WT         ML    L  4  0.022156  0.05231    0.625 
 SOST TG 6 month WT         ML    R  7  0.063178  0.12362    0.509 
SOST TG 8 month DEF         AP    L  2  0.036697  0.12296  121.651 
SOST TG 8 month DEF         AP    R  2  0.031682  0.10615  105.026 
SOST TG 8 month DEF         ML    L  1         *        *        * 
SOST TG 8 month DEF         ML    R  2  0.083828  0.28087  277.886 
 SOST TG 8 month TG         AP    L  2  0.022497  0.07538   74.579 
 SOST TG 8 month TG         ML    R  2  0.013044  0.04370   43.239 
 SOST TG 8 month WT         AP    L  2  0.106878  0.35810  354.299 
 SOST TG 8 month WT         AP    R  2  0.072463  0.24279  240.213 
 SOST TG 8 month WT         ML    L  2  0.087053  0.29168  288.580 
 SOST TG 8 month WT         ML    R  2  0.008537  0.02860   28.301 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 80.70, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 1.13, p-value = 0.337 
 
  
Test for Equal Variances: CSA versus Genotype+Phenotype, Bend Direction, Leg  
 
DUE TO LACK OF REPETITION CANNOT RUN GLM WITH ALL FACTORS. BEND DIRECTION 
WILL BE EXCLUDED AS CSA SHOULD NOT DEPEND ON THIS FACTOR. 
 
  
Test for Equal Variances: CSA versus Genotype+Phenotype, Leg  
 
95% Bonferroni confidence intervals for standard deviations 
 
 Genotype+Phenotype  Leg   N     Lower     StDev    Upper 
SOST KO 12 month KO    L   5  0.465962  0.987673    6.194 
SOST KO 12 month KO    R   5  0.313128  0.663719    4.162 
SOST KO 12 month WT    L   2  0.115301  0.372102  237.516 
SOST KO 12 month WT    R   2  0.096392  0.311077  198.563 
 SOST KO 6 month KO    L   4  0.119556  0.274316    2.829 
 SOST KO 6 month KO    R   4  0.134463  0.308519    3.181 
 SOST KO 6 month WT    L   6  0.076218  0.152434    0.710 
 SOST KO 6 month WT    R   6  0.177635  0.355266    1.655 
SOST TG 6 month DEF    L   9  0.094006  0.168023    0.498 
SOST TG 6 month DEF    R   9  0.077993  0.139402    0.413 
 SOST TG 6 month TG    L   2  0.004599  0.014841    9.473 
 SOST TG 6 month TG    R   2  0.008552  0.027599   17.616 
 SOST TG 6 month WT    L  11  0.086897  0.147959    0.375 
 SOST TG 6 month WT    R  11  0.066959  0.114010    0.289 
SOST TG 8 month DEF    L   3  0.033896  0.087638    2.478 
SOST TG 8 month DEF    R   4  0.088213  0.202402    2.087 
 SOST TG 8 month TG    L   2  0.023357  0.075379   48.115 
 SOST TG 8 month TG    R   2  0.013542  0.043704   27.896 
 SOST TG 8 month WT    L   4  0.125280  0.287449    2.964 
 SOST TG 8 month WT    R   4  0.092164  0.211467    2.180 
 
 
Bartlett's Test (Normal Distribution) 
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Test statistic = 73.79, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 3.09, p-value = 0.000 
 
  
Test for Equal Variances: CSA versus Genotype+Phenotype, Leg  
 
P-VAL < 0.05 TELLS THAT CSA IS DIFFERENT BASED ON GENOTYPE+PHENOTYPE AND LEG. 
 
  
General Linear Model: CSA versus Genotype+Phenotype, Leg  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Leg                 fixed       2  L, R 
 
 
Analysis of Variance for CSA, using Adjusted SS for Tests 
 
Source                  DF    Seq SS   Adj SS   Adj MS      F      P 
Genotype+Phenotype       9   93.7382  93.7417  10.4157  95.29  0.000 
Leg                      1    0.0916   0.0637   0.0637   0.58  0.448 
Genotype+Phenotype*Leg   9    0.7585   0.7585   0.0843   0.77  0.643 
Error                   77    8.4170   8.4170   0.1093 
Total                   96  103.0053 
 
 
S = 0.330622   R-Sq = 91.83%   R-Sq(adj) = 89.81% 
 
 
Unusual Observations for CSA 
 
Obs      CSA      Fit   SE Fit  Residual  St Resid 
 90  4.70690  3.95674  0.14786   0.75015      2.54 R 
 92  3.28288  3.95674  0.14786  -0.67387     -2.28 R 
 93  2.98779  3.95264  0.14786  -0.96485     -3.26 R 
 94  2.96983  3.95674  0.14786  -0.98692     -3.34 R 
 95  4.57234  3.95264  0.14786   0.61970      2.10 R 
 96  5.27709  3.95674  0.14786   1.32034      4.46 R 
 97  4.58869  3.95264  0.14786   0.63604      2.15 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 12 month KO  10  3.9547  A 
SOST KO 6 month KO    8  2.8581    B 
SOST KO 6 month WT   12  1.7129      C 
SOST KO 12 month WT   4  1.3174      C D 
SOST TG 6 month WT   22  1.0365        D 
SOST TG 8 month WT    8  1.0280        D 
SOST TG 6 month DEF  18  0.9375        D 
SOST TG 8 month TG    4  0.9038        D 
SOST TG 6 month TG    4  0.8793        D 
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SOST TG 8 month DEF   7  0.8354        D 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Leg   N    Mean  Grouping 
R    49  1.5765  A 
L    48  1.5162  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype   Leg   N    Mean  Grouping 
SOST KO 12 month KO  L     5  3.9567  A 
SOST KO 12 month KO  R     5  3.9526  A 
SOST KO 6 month KO   R     4  3.0604    B 
SOST KO 6 month KO   L     4  2.6557    B C 
SOST KO 6 month WT   R     6  1.9059      C D 
SOST KO 6 month WT   L     6  1.5199        D E 
SOST KO 12 month WT  L     2  1.3241        D E 
SOST KO 12 month WT  R     2  1.3108        D E 
SOST TG 8 month WT   L     4  1.0660          E 
SOST TG 6 month WT   L    11  1.0420          E 
SOST TG 6 month WT   R    11  1.0310          E 
SOST TG 8 month WT   R     4  0.9899          E 
SOST TG 8 month TG   L     2  0.9787        D E 
SOST TG 6 month DEF  L     9  0.9711          E 
SOST TG 6 month DEF  R     9  0.9039          E 
SOST TG 6 month TG   R     2  0.8936          E 
SOST TG 8 month DEF  R     4  0.8884          E 
SOST TG 6 month TG   L     2  0.8650          E 
SOST TG 8 month TG   R     2  0.8288          E 
SOST TG 8 month DEF  L     3  0.7825          E 
 
Means that do not share a letter are significantly different. 
 
  
Interaction Plot for CSA  
 
  
Probability Plot of SRES1 
 
TEST FOR NORMALITY SHOWS OUTLIERS WELL ABOVE 2 STDEV FROM THE MEAN. THESE 
3 OBSERVATIONS WILL BE EXCLUDED FROM THIS DATA SET (7592R, 7593L, 7594L). 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Leg  
 
95% Bonferroni confidence intervals for standard deviations 
 
 Genotype+Phenotype  Leg   N    Lower    StDev    Upper 
SOST KO 12 month KO    L   5  1.57570  3.33992    20.95 
SOST KO 12 month KO    R   5  1.05887  2.24444    14.08 
SOST KO 12 month WT    L   2  0.49319  1.59164  1015.96 
SOST KO 12 month WT    R   2  0.41231  1.33061   849.34 
 SOST KO 6 month KO    L   4  0.41755  0.95805     9.88 
 SOST KO 6 month KO    R   4  0.46961  1.07751    11.11 
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 SOST KO 6 month WT    L   6  0.25253  0.50506     2.35 
 SOST KO 6 month WT    R   6  0.58856  1.17710     5.48 
SOST TG 6 month DEF    L   9  0.30158  0.53903     1.60 
SOST TG 6 month DEF    R   9  0.25021  0.44721     1.33 
 SOST TG 6 month TG    L   2  0.01967  0.06348    40.52 
 SOST TG 6 month TG    R   2  0.03658  0.11805    75.35 
 SOST TG 6 month WT    L  11  0.27566  0.46936     1.19 
 SOST TG 6 month WT    R  11  0.21241  0.36166     0.92 
SOST TG 8 month DEF    L   3  0.12556  0.32464     9.18 
SOST TG 8 month DEF    R   4  0.30809  0.70689     7.29 
 SOST TG 8 month TG    L   2  0.09991  0.32243   205.81 
 SOST TG 8 month TG    R   2  0.05793  0.18694   119.32 
 SOST TG 8 month WT    L   4  0.43754  1.00392    10.35 
 SOST TG 8 month WT    R   4  0.32188  0.73855     7.62 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 75.05, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 3.20, p-value = 0.000 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Leg  
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Leg  
 
95% Bonferroni confidence intervals for standard deviations 
 
 Genotype+Phenotype  Leg   N     Lower    StDev    Upper 
SOST KO 12 month KO    L   3  0.990766  2.56159    72.43 
SOST KO 12 month KO    R   4  0.658238  1.51030    15.57 
SOST KO 12 month WT    L   2  0.493193  1.59164  1015.96 
SOST KO 12 month WT    R   2  0.412308  1.33061   849.34 
 SOST KO 6 month KO    L   4  0.417550  0.95805     9.88 
 SOST KO 6 month KO    R   4  0.469613  1.07751    11.11 
 SOST KO 6 month WT    L   6  0.252531  0.50506     2.35 
 SOST KO 6 month WT    R   6  0.588556  1.17710     5.48 
SOST TG 6 month DEF    L   9  0.301578  0.53903     1.60 
SOST TG 6 month DEF    R   9  0.250208  0.44721     1.33 
 SOST TG 6 month TG    L   2  0.019671  0.06348    40.52 
 SOST TG 6 month TG    R   2  0.036580  0.11805    75.35 
 SOST TG 6 month WT    L  11  0.275658  0.46936     1.19 
 SOST TG 6 month WT    R  11  0.212408  0.36166     0.92 
SOST TG 8 month DEF    L   3  0.125565  0.32464     9.18 
SOST TG 8 month DEF    R   4  0.308086  0.70689     7.29 
 SOST TG 8 month TG    L   2  0.099910  0.32243   205.81 
 SOST TG 8 month TG    R   2  0.057926  0.18694   119.32 
 SOST TG 8 month WT    L   4  0.437541  1.00392    10.35 
 SOST TG 8 month WT    R   4  0.321885  0.73855     7.62 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 46.16, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 2.77, p-value = 0.001 
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Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Leg  
 
THERE IS NO EQUAL VARIANCE. 
 
  
General Linear Model: CSA_1 versus Genotype+Phenotype, Leg  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Leg                 fixed       2  L, R 
 
 
Analysis of Variance for CSA_1, using Adjusted SS for Tests 
 
Source                  DF   Seq SS   Adj SS  Adj MS       F      P 
Genotype+Phenotype       9  78.8471  77.0300  8.5589  140.78  0.000 
Leg                      1   0.1876   0.1548  0.1548    2.55  0.115 
Genotype+Phenotype*Leg   9   0.8704   0.8704  0.0967    1.59  0.134 
Error                   74   4.4989   4.4989  0.0608 
Total                   93  84.4039 
 
 
S = 0.246569   R-Sq = 94.67%   R-Sq(adj) = 93.30% 
 
 
Unusual Observations for CSA_1 
 
Obs    CSA_1      Fit   SE Fit  Residual  St Resid 
 83  2.44513  1.90594  0.10066   0.53919      2.40 R 
 90  4.70690  3.84560  0.14236   0.86129      4.28 R 
 92  3.28288  3.84560  0.14236  -0.56273     -2.80 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 12 month KO   7  4.0197  A 
SOST KO 6 month KO    8  2.8581    B 
SOST KO 6 month WT   12  1.7129      C 
SOST KO 12 month WT   4  1.3174      C D 
SOST TG 6 month WT   22  1.0365        D 
SOST TG 8 month WT    8  1.0280        D 
SOST TG 6 month DEF  18  0.9375        D 
SOST TG 8 month TG    4  0.9038        D 
SOST TG 6 month TG    4  0.8793        D 
SOST TG 8 month DEF   7  0.8354        D 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Leg   N    Mean  Grouping 
R    48  1.6007  A 
L    46  1.5051  A 
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Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype   Leg   N    Mean  Grouping 
SOST KO 12 month KO  R     4  4.1939  A 
SOST KO 12 month KO  L     3  3.8456  A 
SOST KO 6 month KO   R     4  3.0604    B 
SOST KO 6 month KO   L     4  2.6557    B 
SOST KO 6 month WT   R     6  1.9059      C 
SOST KO 6 month WT   L     6  1.5199      C D 
SOST KO 12 month WT  L     2  1.3241      C D E 
SOST KO 12 month WT  R     2  1.3108      C D E 
SOST TG 8 month WT   L     4  1.0660        D E 
SOST TG 6 month WT   L    11  1.0420          E 
SOST TG 6 month WT   R    11  1.0310          E 
SOST TG 8 month WT   R     4  0.9899        D E 
SOST TG 8 month TG   L     2  0.9787        D E 
SOST TG 6 month DEF  L     9  0.9711          E 
SOST TG 6 month DEF  R     9  0.9039          E 
SOST TG 6 month TG   R     2  0.8936        D E 
SOST TG 8 month DEF  R     4  0.8884          E 
SOST TG 6 month TG   L     2  0.8650        D E 
SOST TG 8 month TG   R     2  0.8288        D E 
SOST TG 8 month DEF  L     3  0.7825          E 
 
Means that do not share a letter are significantly different. 
 
  
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Ixx_1 versus Genotype+Phenotype, Leg  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Leg                 fixed       2  L, R 
 
 
Analysis of Variance for Ixx_1, using Adjusted SS for Tests 
 
Source                  DF    Seq SS    Adj SS   Adj MS      F      P 
Genotype+Phenotype       9  11.70817  11.31846  1.25761  21.75  0.000 
Leg                      1   0.15947   0.19304  0.19304   3.34  0.072 
Genotype+Phenotype*Leg   9   0.49026   0.49026  0.05447   0.94  0.494 
Error                   76   4.39524   4.39524  0.05783 
Total                   95  16.75314 
 
 
S = 0.240483   R-Sq = 73.76%   R-Sq(adj) = 67.21% 
 
 
Unusual Observations for Ixx_1 
 
Obs    Ixx_1      Fit   SE Fit  Residual  St Resid 
 49  0.78461  0.35937  0.12024   0.42524      2.04 R 
 73  1.28804  0.69323  0.09818   0.59482      2.71 R 
 75  1.45154  0.69323  0.09818   0.75831      3.45 R 
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 81  0.24481  0.69323  0.09818  -0.44842     -2.04 R 
 85  2.42895  1.47377  0.10755   0.95518      4.44 R 
 93  0.55750  1.47377  0.10755  -0.91626     -4.26 R 
 95  0.99449  1.47377  0.10755  -0.47928     -2.23 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N  Mean  Grouping 
SOST KO 12 month KO   9   1.3  A 
SOST KO 6 month KO    8   0.8    B 
SOST KO 6 month WT   12   0.6    B C 
SOST KO 12 month WT   4   0.4    B C D 
SOST TG 8 month WT    8   0.3      C D 
SOST TG 6 month WT   22   0.2        D 
SOST TG 6 month TG    4   0.2      C D 
SOST TG 8 month TG    4   0.2      C D 
SOST TG 6 month DEF  18   0.2        D 
SOST TG 8 month DEF   7   0.2        D 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Leg   N  Mean  Grouping 
R    49   0.5  A 
L    47   0.4  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype   Leg   N  Mean  Grouping 
SOST KO 12 month KO  R     5   1.5  A 
SOST KO 12 month KO  L     4   1.1  A B 
SOST KO 6 month KO   R     4   0.8    B C 
SOST KO 6 month KO   L     4   0.8    B C D 
SOST KO 6 month WT   R     6   0.7    B C D 
SOST KO 12 month WT  R     2   0.5    B C D E 
SOST KO 6 month WT   L     6   0.4      C D E 
SOST TG 8 month WT   L     4   0.4      C D E 
SOST TG 6 month TG   R     2   0.3      C D E 
SOST KO 12 month WT  L     2   0.3      C D E 
SOST TG 6 month WT   R    11   0.2          E 
SOST TG 8 month TG   R     2   0.2      C D E 
SOST TG 8 month WT   R     4   0.2      C D E 
SOST TG 6 month DEF  L     9   0.2          E 
SOST TG 6 month WT   L    11   0.2          E 
SOST TG 8 month DEF  R     4   0.2        D E 
SOST TG 6 month DEF  R     9   0.2          E 
SOST TG 8 month TG   L     2   0.2      C D E 
SOST TG 8 month DEF  L     3   0.1        D E 
SOST TG 6 month TG   L     2   0.1      C D E 
 
Means that do not share a letter are significantly different. 
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Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: E versus Genotype+Phenotype, Bend Direction  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for E, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS      F      P 
Genotype+Phenotype                  9  320.357  315.522  35.058   7.93  0.000 
Bend Direction                      1   55.869   58.883  58.883  13.33  0.000 
Genotype+Phenotype*Bend Direction   9   22.948   22.948   2.550   0.58  0.812 
Error                              77  340.203  340.203   4.418 
Total                              96  739.377 
 
 
S = 2.10196   R-Sq = 53.99%   R-Sq(adj) = 42.63% 
 
 
Unusual Observations for E 
 
Obs        E     Fit  SE Fit  Residual  St Resid 
 31   9.6009  5.2415  0.7007    4.3594      2.20 R 
 44   2.2839  7.0915  0.7007   -4.8076     -2.43 R 
 55  12.0800  7.1925  1.0510    4.8875      2.68 R 
 86   2.1841  6.3668  1.4863   -4.1827     -2.81 R 
 88  10.5495  6.3668  1.4863    4.1827      2.81 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST TG 6 month DEF  18  6.1665  A 
SOST TG 8 month DEF   7  6.0325  A 
SOST TG 8 month WT    8  5.4316  A 
SOST TG 6 month WT   22  5.0449  A 
SOST TG 8 month TG    4  4.8171  A B 
SOST KO 12 month WT   4  4.6147  A B 
SOST TG 6 month TG    4  2.8387  A B 
SOST KO 6 month WT   12  2.0889    B 
SOST KO 12 month KO  10  1.6407    B 
SOST KO 6 month KO    8  1.3179    B 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
AP         49  4.9170  A 
ML         48  3.0817    B 
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Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST TG 8 month WT   AP          4  7.1925  A B C 
SOST TG 8 month DEF  AP          4  7.1837  A B C 
SOST TG 6 month DEF  AP          9  7.0915  A 
SOST KO 12 month WT  AP          2  6.3668  A B C D E 
SOST TG 8 month TG   AP          2  5.8945  A B C D E 
SOST TG 6 month WT   AP         11  5.4497  A B C D 
SOST TG 6 month DEF  ML          9  5.2415  A B C D E 
SOST TG 8 month DEF  ML          3  4.8813  A B C D E 
SOST TG 6 month WT   ML         11  4.6402  A B C D E 
SOST TG 6 month TG   AP          2  3.7737  A B C D E 
SOST TG 8 month TG   ML          2  3.7397  A B C D E 
SOST TG 8 month WT   ML          4  3.6708  A B C D E 
SOST KO 12 month WT  ML          2  2.8627  A B C D E 
SOST KO 6 month WT   AP          6  2.4255      C D E 
SOST KO 6 month KO   AP          4  2.0228    B C D E 
SOST TG 6 month TG   ML          2  1.9037  A B C D E 
SOST KO 12 month KO  AP          5  1.7698        D E 
SOST KO 6 month WT   ML          6  1.7523        D E 
SOST KO 12 month KO  ML          5  1.5117        D E 
SOST KO 6 month KO   ML          4  0.6131          E 
 
Means that do not share a letter are significantly different. 
 
  
Probability Plot of SRES1  
 
DUE TO TEST FOR NORMALITY SHOWING NORMAL DISTRIBUTION WITH NO OUTLIERS, NO 
DATA POINTS WILL BE EXCLUDED. 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N    Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.26325  0.55800     3.50 
SOST KO 12 month KO         ML   5  0.24872  0.52720     3.31 
SOST KO 12 month WT         AP   2  1.23321  3.97985  2540.37 
SOST KO 12 month WT         ML   2  0.05061  0.16332   104.25 
 SOST KO 6 month KO         AP   4  0.21908  0.50266     5.18 
 SOST KO 6 month KO         ML   4  0.14360  0.32949     3.40 
 SOST KO 6 month WT         AP   6  0.37231  0.74461     3.47 
 SOST KO 6 month WT         ML   6  0.35239  0.70478     3.28 
SOST TG 6 month DEF         AP   9  0.72357  1.29328     3.83 
SOST TG 6 month DEF         ML   9  0.72441  1.29479     3.84 
 SOST TG 6 month TG         AP   2  0.09024  0.29123   185.89 
 SOST TG 6 month TG         ML   2  0.46251  1.49263   952.76 
 SOST TG 6 month WT         AP  11  0.58110  0.98944     2.51 
 SOST TG 6 month WT         ML  11  0.67158  1.14349     2.90 
SOST TG 8 month DEF         AP   4  0.37368  0.85738     8.84 
SOST TG 8 month DEF         ML   3  0.34045  0.88021    24.89 
 SOST TG 8 month TG         AP   2  0.61790  1.99410  1272.85 
 SOST TG 8 month TG         ML   2  0.22465  0.72501   462.78 
 SOST TG 8 month WT         AP   4  0.81556  1.87128    19.29 
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 SOST TG 8 month WT         ML   4  0.53679  1.23164    12.70 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 29.59, p-value = 0.057 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 2.37, p-value = 0.004 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
THERE IS NO EQUAL VARIANCE. 
 
  
General Linear Model: E versus Genotype+Phenotype, Bend Direction  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for E, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS      F      P 
Genotype+Phenotype                  9  320.357  315.522  35.058   7.93  0.000 
Bend Direction                      1   55.869   58.883  58.883  13.33  0.000 
Genotype+Phenotype*Bend Direction   9   22.948   22.948   2.550   0.58  0.812 
Error                              77  340.203  340.203   4.418 
Total                              96  739.377 
 
 
S = 2.10196   R-Sq = 53.99%   R-Sq(adj) = 42.63% 
 
 
Unusual Observations for E 
 
Obs        E     Fit  SE Fit  Residual  St Resid 
 31   9.6009  5.2415  0.7007    4.3594      2.20 R 
 44   2.2839  7.0915  0.7007   -4.8076     -2.43 R 
 55  12.0800  7.1925  1.0510    4.8875      2.68 R 
 86   2.1841  6.3668  1.4863   -4.1827     -2.81 R 
 88  10.5495  6.3668  1.4863    4.1827      2.81 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST TG 6 month DEF  18  6.1665  A 
SOST TG 8 month DEF   7  6.0325  A 
SOST TG 8 month WT    8  5.4316  A 
SOST TG 6 month WT   22  5.0449  A 
SOST TG 8 month TG    4  4.8171  A B 
SOST KO 12 month WT   4  4.6147  A B 
SOST TG 6 month TG    4  2.8387  A B 
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SOST KO 6 month WT   12  2.0889    B 
SOST KO 12 month KO  10  1.6407    B 
SOST KO 6 month KO    8  1.3179    B 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
AP         49  4.9170  A 
ML         48  3.0817    B 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST TG 8 month WT   AP          4  7.1925  A B C 
SOST TG 8 month DEF  AP          4  7.1837  A B C 
SOST TG 6 month DEF  AP          9  7.0915  A 
SOST KO 12 month WT  AP          2  6.3668  A B C D E 
SOST TG 8 month TG   AP          2  5.8945  A B C D E 
SOST TG 6 month WT   AP         11  5.4497  A B C D 
SOST TG 6 month DEF  ML          9  5.2415  A B C D E 
SOST TG 8 month DEF  ML          3  4.8813  A B C D E 
SOST TG 6 month WT   ML         11  4.6402  A B C D E 
SOST TG 6 month TG   AP          2  3.7737  A B C D E 
SOST TG 8 month TG   ML          2  3.7397  A B C D E 
SOST TG 8 month WT   ML          4  3.6708  A B C D E 
SOST KO 12 month WT  ML          2  2.8627  A B C D E 
SOST KO 6 month WT   AP          6  2.4255      C D E 
SOST KO 6 month KO   AP          4  2.0228    B C D E 
SOST TG 6 month TG   ML          2  1.9037  A B C D E 
SOST KO 12 month KO  AP          5  1.7698        D E 
SOST KO 6 month WT   ML          6  1.7523        D E 
SOST KO 12 month KO  ML          5  1.5117        D E 
SOST KO 6 month KO   ML          4  0.6131          E 
 
Means that do not share a letter are significantly different. 
 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Yield Force versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Yield Force, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS      F      P 
Genotype+Phenotype                  9  20476.1  20457.0  2273.0  11.64  0.000 
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Bend Direction                      1   1232.7    783.2   783.2   4.01  0.049 
Genotype+Phenotype*Bend Direction   9   1584.2   1584.2   176.0   0.90  0.528 
Error                              77  15036.9  15036.9   195.3 
Total                              96  38329.9 
 
 
S = 13.9744   R-Sq = 60.77%   R-Sq(adj) = 51.09% 
 
 
Unusual Observations for Yield Force 
 
Obs  Yield Force      Fit  SE Fit  Residual  St Resid 
 65      51.9074  23.5825  6.9872   28.3249      2.34 R 
 66      79.8187  54.9027  6.9872   24.9161      2.06 R 
 70       0.1770  54.9027  6.9872  -54.7256     -4.52 R 
 84      14.7553  51.6400  6.2495  -36.8848     -2.95 R 
 94       7.3456  57.3987  6.2495  -50.0531     -4.00 R 
 96      85.2417  57.3987  6.2495   27.8430      2.23 R 
 
R denotes an observation with a large standardized residual. 
 
  
Probability Plot of SRES1 
 
TEST FOR NORMALITY SHOWS OUTLIERS FOR 9203L, 7544L, and 7593L WHICH WILL BE 
EXCLUDED FROM THE ANALYSIS. 
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N     Lower    StDev    Upper 
SOST KO 12 month KO         AP   4  0.229423  0.52640    5.428 
SOST KO 12 month KO         ML   4  0.432059  0.99134   10.222 
SOST KO 12 month WT         AP   2  0.357629  1.15415  736.701 
SOST KO 12 month WT         ML   2  0.254434  0.82112  524.124 
 SOST KO 6 month KO         AP   4  0.957883  2.19782   22.662 
 SOST KO 6 month KO         ML   3  0.315984  0.81696   23.100 
 SOST KO 6 month WT         AP   6  0.530191  1.06037    4.939 
 SOST KO 6 month WT         ML   6  0.467183  0.93435    4.352 
SOST TG 6 month DEF         AP   9  0.208100  0.37195    1.102 
SOST TG 6 month DEF         ML   9  0.223995  0.40036    1.186 
 SOST TG 6 month TG         AP   2  0.110368  0.35618  227.353 
 SOST TG 6 month TG         ML   2  0.102924  0.33216  212.019 
 SOST TG 6 month WT         AP  11  0.247209  0.42092    1.067 
 SOST TG 6 month WT         ML  11  0.290562  0.49474    1.254 
SOST TG 8 month DEF         AP   4  0.096449  0.22130    2.282 
SOST TG 8 month DEF         ML   3  0.234258  0.60567   17.125 
 SOST TG 8 month TG         AP   2  0.245976  0.79382  506.700 
 SOST TG 8 month TG         ML   2  0.203683  0.65733  419.578 
 SOST TG 8 month WT         AP   4  0.154630  0.35479    3.658 
 SOST TG 8 month WT         ML   4  0.090328  0.20725    2.137 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 43.01, p-value = 0.001 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 3.39, p-value = 0.000 
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Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N    Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.80744  1.71149   10.733 
SOST KO 12 month KO         ML   5  1.13113  2.39759   15.036 
SOST KO 12 month WT         AP   2  0.35763  1.15415  736.701 
SOST KO 12 month WT         ML   2  0.25443  0.82112  524.124 
 SOST KO 6 month KO         AP   4  0.95788  2.19782   22.662 
 SOST KO 6 month KO         ML   4  1.34566  3.08756   31.836 
 SOST KO 6 month WT         AP   6  0.53019  1.06037    4.939 
 SOST KO 6 month WT         ML   6  0.46718  0.93435    4.352 
SOST TG 6 month DEF         AP   9  0.20810  0.37195    1.102 
SOST TG 6 month DEF         ML   9  0.22399  0.40036    1.186 
 SOST TG 6 month TG         AP   2  0.11037  0.35618  227.353 
 SOST TG 6 month TG         ML   2  0.10292  0.33216  212.019 
 SOST TG 6 month WT         AP  11  0.24721  0.42092    1.067 
 SOST TG 6 month WT         ML  11  0.29056  0.49474    1.254 
SOST TG 8 month DEF         AP   4  0.09645  0.22130    2.282 
SOST TG 8 month DEF         ML   3  0.23426  0.60567   17.125 
 SOST TG 8 month TG         AP   2  0.24598  0.79382  506.700 
 SOST TG 8 month TG         ML   2  0.20368  0.65733  419.578 
 SOST TG 8 month WT         AP   4  0.15463  0.35479    3.658 
 SOST TG 8 month WT         ML   4  0.09033  0.20725    2.137 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 77.97, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 1.99, p-value = 0.018 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
ALTHOUGH P-VALUE INCLUDING OUTLIERS IS GREATER THAN WITHOUT THE OUTLIERS, 
THE RESULT DOES NOT CHANGE SIGNIFICANCE AND AS SUCH THE OUTLIERS WILL BE 
EXCLUDED. 
 
General Linear Model: Yield Force_ versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Yield Force_1, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS      F      P 
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Genotype+Phenotype                  9  26456.2  27663.0  3073.7  36.62  0.000 
Bend Direction                      1   1686.8   1325.8  1325.8  15.79  0.000 
Genotype+Phenotype*Bend Direction   9   3460.1   3460.1   384.5   4.58  0.000 
Error                              74   6211.4   6211.4    83.9 
Total                              93  37814.5 
 
 
S = 9.16179   R-Sq = 83.57%   R-Sq(adj) = 79.36% 
 
 
Unusual Observations for Yield Force_1 
 
       Yield 
Obs  Force_1      Fit  SE Fit  Residual  St Resid 
 65  51.9074  23.5825  4.5809   28.3249      3.57 R 
 67   0.6744  23.5825  4.5809  -22.9080     -2.89 R 
 68   1.1169  23.5825  4.5809  -22.4655     -2.83 R 
 71  40.6311  23.5825  4.5809   17.0486      2.15 R 
 72  31.0272  13.2258  3.7403   17.8014      2.13 R 
 74  30.0507  13.2258  3.7403   16.8249      2.01 R 
 82   6.5979  25.7456  3.7403  -19.1477     -2.29 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 12 month KO   8  65.387  A 
SOST KO 6 month KO    7  48.363    B 
SOST KO 6 month WT   12  19.486      C 
SOST KO 12 month WT   4  16.906      C 
SOST TG 6 month WT   22  12.875      C 
SOST TG 6 month DEF  18  10.481      C 
SOST TG 8 month DEF   7  10.072      C 
SOST TG 8 month WT    8   9.523      C 
SOST TG 8 month TG    4   8.190      C 
SOST TG 6 month TG    4   5.977      C 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
ML         46  25.150  A 
AP         48  16.302    B 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST KO 6 month KO   ML          3  73.145  A 
SOST KO 12 month KO  ML          4  69.912  A 
SOST KO 12 month KO  AP          4  60.861  A 
SOST KO 6 month WT   ML          6  25.746    B 
SOST KO 6 month KO   AP          4  23.582    B C 
SOST KO 12 month WT  ML          2  18.396    B C 
SOST KO 12 month WT  AP          2  15.416    B C 
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SOST TG 6 month WT   ML         11  14.708    B C 
SOST TG 6 month DEF  ML          9  13.824    B C 
SOST KO 6 month WT   AP          6  13.226    B C 
SOST TG 6 month WT   AP         11  11.042    B C 
SOST TG 8 month DEF  ML          3  10.517    B C 
SOST TG 8 month WT   ML          4   9.670    B C 
SOST TG 8 month DEF  AP          4   9.626    B C 
SOST TG 8 month WT   AP          4   9.375    B C 
SOST TG 8 month TG   AP          2   8.730    B C 
SOST TG 6 month TG   ML          2   7.927    B C 
SOST TG 8 month TG   ML          2   7.651    B C 
SOST TG 6 month DEF  AP          9   7.139      C 
SOST TG 6 month TG   AP          2   4.027    B C 
 
Means that do not share a letter are significantly different. 
 
 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Ultimate For versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Ultimate Force, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS      F      P 
Genotype+Phenotype                  9  30530.1  30524.8  3391.6  99.38  0.000 
Bend Direction                      1    698.9    524.7   524.7  15.37  0.000 
Genotype+Phenotype*Bend Direction   9    607.2    607.2    67.5   1.98  0.053 
Error                              77   2627.7   2627.7    34.1 
Total                              96  34463.9 
 
 
S = 5.84180   R-Sq = 92.38%   R-Sq(adj) = 90.49% 
 
 
Unusual Observations for Ultimate Force 
 
     Ultimate 
Obs     Force      Fit  SE Fit  Residual  St Resid 
 66   80.1300  65.6761  2.9209   14.4539      2.86 R 
 69   77.8290  65.6761  2.9209   12.1529      2.40 R 
 70   42.9596  65.6761  2.9209  -22.7165     -4.49 R 
 85   58.9935  69.5306  2.6125  -10.5371     -2.02 R 
 90   70.3674  59.6747  2.6125   10.6927      2.05 R 
 96   85.2417  69.5306  2.6125   15.7111      3.01 R 
 
R denotes an observation with a large standardized residual. 
 
  
Probability Plot of SRES1 
 
TEST FOR NORMALITY SHOWED OUTLIERS FOR 9201L, 9203L, and 7594L WHICH WILL BE 
EXCLUDED FROM ANALYSIS. 
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Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N    Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.64565  1.36855    8.583 
SOST KO 12 month KO         ML   5  0.97616  2.06912   12.976 
SOST KO 12 month WT         AP   2  0.26742  0.86301  550.864 
SOST KO 12 month WT         ML   2  0.32326  1.04323  665.904 
 SOST KO 6 month KO         AP   4  0.60239  1.38216   14.252 
 SOST KO 6 month KO         ML   4  1.48196  3.40028   35.061 
 SOST KO 6 month WT         AP   6  0.54941  1.09881    5.118 
 SOST KO 6 month WT         ML   6  0.36818  0.73635    3.430 
SOST TG 6 month DEF         AP   9  0.39397  0.70416    2.087 
SOST TG 6 month DEF         ML   9  0.37605  0.67213    1.992 
 SOST TG 6 month TG         AP   2  0.24378  0.78673  502.179 
 SOST TG 6 month TG         ML   2  0.09243  0.29829  190.401 
 SOST TG 6 month WT         AP  11  0.41149  0.70064    1.776 
 SOST TG 6 month WT         ML  11  0.27008  0.45986    1.166 
SOST TG 8 month DEF         AP   4  0.42440  0.97378   10.041 
SOST TG 8 month DEF         ML   3  0.44355  1.14678   32.426 
 SOST TG 8 month TG         AP   2  0.23698  0.76479  488.173 
 SOST TG 8 month TG         ML   2  0.23925  0.77211  492.842 
 SOST TG 8 month WT         AP   4  0.26196  0.60107    6.198 
 SOST TG 8 month WT         ML   4  0.04048  0.09288    0.958 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 50.85, p-value = 0.000 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 3.18, p-value = 0.000 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N     Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.645649  1.36855     8.58 
SOST KO 12 month KO         ML   4  0.607226  1.39325    14.37 
SOST KO 12 month WT         AP   2  0.267415  0.86301   550.86 
SOST KO 12 month WT         ML   2  0.323261  1.04323   665.90 
 SOST KO 6 month KO         AP   4  0.602393  1.38216    14.25 
 SOST KO 6 month KO         ML   2  0.694812  2.24231  1431.28 
 SOST KO 6 month WT         AP   6  0.549410  1.09881     5.12 
 SOST KO 6 month WT         ML   6  0.368180  0.73635     3.43 
SOST TG 6 month DEF         AP   9  0.393967  0.70416     2.09 
SOST TG 6 month DEF         ML   9  0.376045  0.67213     1.99 
 SOST TG 6 month TG         AP   2  0.243781  0.78673   502.18 
 SOST TG 6 month TG         ML   2  0.092429  0.29829   190.40 
 SOST TG 6 month WT         AP  11  0.411491  0.70064     1.78 
 SOST TG 6 month WT         ML  11  0.270077  0.45986     1.17 
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SOST TG 8 month DEF         AP   4  0.424404  0.97378    10.04 
SOST TG 8 month DEF         ML   3  0.443550  1.14678    32.43 
 SOST TG 8 month TG         AP   2  0.236982  0.76479   488.17 
 SOST TG 8 month TG         ML   2  0.239249  0.77211   492.84 
 SOST TG 8 month WT         AP   4  0.261964  0.60107     6.20 
 SOST TG 8 month WT         ML   4  0.040479  0.09288     0.96 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 26.61, p-value = 0.114 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 1.71, p-value = 0.053 
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
  
General Linear Model: Ultimate For versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Ultimate Force_1, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS  Adj MS       F      P 
Genotype+Phenotype                  9  24875.1  25483.9  2831.5  134.31  0.000 
Bend Direction                      1    551.1    502.2   502.2   23.82  0.000 
Genotype+Phenotype*Bend Direction   9    615.1    615.1    68.3    3.24  0.002 
Error                              74   1560.1   1560.1    21.1 
Total                              93  27601.5 
 
 
S = 4.59158   R-Sq = 94.35%   R-Sq(adj) = 92.90% 
 
 
Unusual Observations for Ultimate Force_1 
 
     Ultimate 
Obs   Force_1      Fit  SE Fit  Residual  St Resid 
 64   61.7859  69.8074  3.2467   -8.0215     -2.47 R 
 69   77.8290  69.8074  3.2467    8.0215      2.47 R 
 71   40.6311  49.3462  2.2958   -8.7151     -2.19 R 
 81   15.1245  24.7182  1.8745   -9.5937     -2.29 R 
 84   51.0223  59.6747  2.0534   -8.6523     -2.11 R 
 90   70.3674  59.6747  2.0534   10.6927      2.60 R 
 92   74.9481  65.6029  2.2958    9.3452      2.35 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 12 month KO   9  62.639  A 
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SOST KO 6 month KO    6  59.577  A 
SOST KO 6 month WT   12  30.074    B 
SOST KO 12 month WT   4  25.541    B C 
SOST TG 6 month WT   22  18.630      C D 
SOST TG 6 month DEF  18  14.422        D 
SOST TG 8 month TG    4  13.849        D 
SOST TG 8 month WT    8  13.337        D 
SOST TG 8 month DEF   7  13.060        D 
SOST TG 6 month TG    4  11.396        D 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
ML         45  29.002  A 
AP         49  23.503    B 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST KO 6 month KO   ML          2  69.807  A 
SOST KO 12 month KO  ML          4  65.603  A 
SOST KO 12 month KO  AP          5  59.675  A B 
SOST KO 6 month KO   AP          4  49.346    B 
SOST KO 6 month WT   ML          6  35.429      C 
SOST KO 12 month WT  ML          2  29.335      C D 
SOST KO 6 month WT   AP          6  24.718        D 
SOST KO 12 month WT  AP          2  21.747      C D E 
SOST TG 6 month WT   ML         11  20.568        D E 
SOST TG 6 month WT   AP         11  16.691        D E 
SOST TG 6 month DEF  ML          9  15.408          E 
SOST TG 8 month TG   ML          2  14.859        D E 
SOST TG 8 month DEF  AP          4  13.798          E 
SOST TG 6 month TG   ML          2  13.612        D E 
SOST TG 8 month WT   AP          4  13.600          E 
SOST TG 6 month DEF  AP          9  13.436          E 
SOST TG 8 month WT   ML          4  13.074          E 
SOST TG 8 month TG   AP          2  12.839        D E 
SOST TG 8 month DEF  ML          3  12.322          E 
SOST TG 6 month TG   AP          2   9.180          E 
 
Means that do not share a letter are significantly different. 
 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Post Yield D versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
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Analysis of Variance for Post Yield Displacement, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS   Adj MS     F      P 
Genotype+Phenotype                  9  0.29652  0.31080  0.03453  0.86  0.565 
Bend Direction                      1  0.00869  0.02048  0.02048  0.51  0.478 
Genotype+Phenotype*Bend Direction   9  0.31422  0.31422  0.03491  0.87  0.557 
Error                              77  3.09713  3.09713  0.04022 
Total                              96  3.71655 
 
 
S = 0.200555   R-Sq = 16.67%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Post Yield Displacement 
 
       Post Yield 
Obs  Displacement       Fit    SE Fit  Residual  St Resid 
 15      0.705207  0.148239  0.066852  0.556968      2.95 R 
 38      0.591390  0.191330  0.060470  0.400060      2.09 R 
 63      0.748680  0.382418  0.115791  0.366263      2.24 R 
 68      0.629456  0.256752  0.100278  0.372704      2.15 R 
 
R denotes an observation with a large standardized residual. 
 
  
Probability Plot of SRES1  
 
TEST FOR NORMALITY  IS VIOLATED AND SHOWS AN OUTLIER FOR 8641L WHICH WILL BE 
EXCLUDED FROM THE ANALYSIS. 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N     Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.416800  0.88347     5.54 
SOST KO 12 month KO         ML   5  0.302717  0.64165     4.02 
SOST KO 12 month WT         AP   2  0.772921  2.49438  1592.18 
SOST KO 12 month WT         ML   2  0.399296  1.28861   822.53 
 SOST KO 6 month KO         AP   4  0.780953  1.79186    18.48 
 SOST KO 6 month KO         ML   4  0.555489  1.27454    13.14 
 SOST KO 6 month WT         AP   6  0.432483  0.86496     4.03 
 SOST KO 6 month WT         ML   6  0.561167  1.12232     5.23 
SOST TG 6 month DEF         AP   9  0.499176  0.89221     2.64 
SOST TG 6 month DEF         ML   9  0.660985  1.18142     3.50 
 SOST TG 6 month TG         AP   2  0.544319  1.75664  1121.27 
 SOST TG 6 month TG         ML   2  0.527356  1.70189  1086.33 
 SOST TG 6 month WT         AP  11  0.571560  0.97319     2.47 
 SOST TG 6 month WT         ML  11  0.641777  1.09275     2.77 
SOST TG 8 month DEF         AP   4  0.203935  0.46792     4.82 
SOST TG 8 month DEF         ML   3  0.750937  1.94152    54.90 
 SOST TG 8 month TG         AP   2  0.465948  1.50371   959.83 
 SOST TG 8 month TG         ML   2  0.339199  1.09467   698.74 
 SOST TG 8 month WT         AP   4  0.576610  1.32301    13.64 
 SOST TG 8 month WT         ML   4  0.254897  0.58485     6.03 
 
 
Bartlett's Test (Normal Distribution) 
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Test statistic = 13.63, p-value = 0.805 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 0.73, p-value = 0.780 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N     Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.416800  0.88347     5.54 
SOST KO 12 month KO         ML   5  0.302717  0.64165     4.02 
SOST KO 12 month WT         AP   2  0.772921  2.49438  1592.18 
SOST KO 12 month WT         ML   2  0.399296  1.28861   822.53 
 SOST KO 6 month KO         AP   4  0.780953  1.79186    18.48 
 SOST KO 6 month KO         ML   4  0.555489  1.27454    13.14 
 SOST KO 6 month WT         AP   6  0.432483  0.86496     4.03 
 SOST KO 6 month WT         ML   6  0.561167  1.12232     5.23 
SOST TG 6 month DEF         AP   9  0.499176  0.89221     2.64 
SOST TG 6 month DEF         ML   8  0.243112  0.44800     1.48 
 SOST TG 6 month TG         AP   2  0.544319  1.75664  1121.27 
 SOST TG 6 month TG         ML   2  0.527356  1.70189  1086.33 
 SOST TG 6 month WT         AP  11  0.571560  0.97319     2.47 
 SOST TG 6 month WT         ML  11  0.641777  1.09275     2.77 
SOST TG 8 month DEF         AP   4  0.203935  0.46792     4.82 
SOST TG 8 month DEF         ML   3  0.750937  1.94152    54.90 
 SOST TG 8 month TG         AP   2  0.465948  1.50371   959.83 
 SOST TG 8 month TG         ML   2  0.339199  1.09467   698.74 
 SOST TG 8 month WT         AP   4  0.576610  1.32301    13.64 
 SOST TG 8 month WT         ML   4  0.254897  0.58485     6.03 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 19.48, p-value = 0.426 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 1.00, p-value = 0.470 
 
  
Test for Equal Variances: SRES1_1 versus Genotype+Phenotype, Bend Direction  
 
ALTHOUGH INCLUDING OUTLIER RESULTS IN MORE EQUAL VARIANCE, EXCLUDING THIS 
POINT DOES NOT EFFECT THE SIGNIFICANCE AND AS SUCH WILL CONTINUE TO BE 
EXCLUDED. 
 
  
General Linear Model: Post Yield D versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
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Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Post Yield Displacement_1, using Adjusted SS for Tests 
 
Source                             DF   Seq SS   Adj SS   Adj MS     F      P 
Genotype+Phenotype                  9  0.31893  0.33884  0.03765  1.04  0.416 
Bend Direction                      1  0.00130  0.01296  0.01296  0.36  0.551 
Genotype+Phenotype*Bend Direction   9  0.36949  0.36949  0.04105  1.14  0.349 
Error                              76  2.74814  2.74814  0.03616 
Total                              95  3.43786 
 
 
S = 0.190157   R-Sq = 20.06%   R-Sq(adj) = 0.08% 
 
 
Unusual Observations for Post Yield Displacement_1 
 
         Post Yield 
Obs  Displacement_1       Fit    SE Fit  Residual  St Resid 
 35        0.521067  0.141663  0.057335  0.379403      2.09 R 
 38        0.591390  0.191330  0.057335  0.400060      2.21 R 
 63        0.748680  0.382418  0.109787  0.366263      2.36 R 
 68        0.629456  0.256752  0.095079  0.372704      2.26 R 
 70        0.442741  0.110685  0.095079  0.332056      2.02 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N     Mean  Grouping 
SOST TG 6 month TG    4  0.29479  A 
SOST TG 8 month WT    8  0.26133  A 
SOST TG 8 month TG    4  0.25399  A 
SOST TG 8 month DEF   7  0.24441  A 
SOST KO 12 month WT   4  0.21078  A 
SOST KO 6 month KO    8  0.18372  A 
SOST TG 6 month WT   22  0.16650  A 
SOST KO 6 month WT   12  0.16014  A 
SOST TG 6 month DEF  17  0.13713  A 
SOST KO 12 month KO  10  0.06117  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N     Mean  Grouping 
ML         47  0.21103  A 
AP         49  0.18376  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N     Mean  Grouping 
SOST TG 8 month DEF  ML          3  0.38242  A 
SOST TG 6 month TG   ML          2  0.37741  A 
SOST TG 8 month WT   ML          4  0.33519  A 
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SOST TG 8 month TG   ML          2  0.32152  A 
SOST KO 12 month WT  AP          2  0.29234  A 
SOST KO 6 month KO   AP          4  0.25675  A 
SOST TG 6 month TG   AP          2  0.21218  A 
SOST TG 6 month DEF  AP          9  0.19564  A 
SOST TG 6 month WT   ML         11  0.19133  A 
SOST KO 6 month WT   AP          6  0.18786  A 
SOST TG 8 month WT   AP          4  0.18747  A 
SOST TG 8 month TG   AP          2  0.18646  A 
SOST TG 6 month WT   AP         11  0.14166  A 
SOST KO 6 month WT   ML          6  0.13241  A 
SOST KO 12 month WT  ML          2  0.12922  A 
SOST KO 6 month KO   ML          4  0.11069  A 
SOST TG 8 month DEF  AP          4  0.10640  A 
SOST TG 6 month DEF  ML          8  0.07862  A 
SOST KO 12 month KO  AP          5  0.07087  A 
SOST KO 12 month KO  ML          5  0.05147  A 
 
Means that do not share a letter are significantly different. 
 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Yield Stress versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Yield Stress, using Adjusted SS for Tests 
 
Source                             DF  Seq SS  Adj SS  Adj MS     F      P 
Genotype+Phenotype                  9   26321   26285    2921  0.64  0.757 
Bend Direction                      1    3815     196     196  0.04  0.836 
Genotype+Phenotype*Bend Direction   9   31676   31676    3520  0.77  0.640 
Error                              77  350029  350029    4546 
Total                              96  411840 
 
 
S = 67.4228   R-Sq = 15.01%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Yield Stress 
 
       Yield 
Obs   Stress      Fit  SE Fit  Residual  St Resid 
 70    0.674  159.668  33.711  -158.993     -2.72 R 
 72  236.161   81.305  27.525   154.856      2.52 R 
 86   39.709  149.394  47.675  -109.684     -2.30 R 
 88  259.078  149.394  47.675   109.684      2.30 R 
 
R denotes an observation with a large standardized residual. 
 
  
Probability Plot of SRES1 
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TEST FOR NORMALITY IS BORDERLINE, BUT SHOWS NORMAL DISTRIBUTION WITH NO 
OUTLIERS. 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N    Lower    StDev    Upper 
SOST KO 12 month KO         AP   5  0.49299  1.04496     6.55 
SOST KO 12 month KO         ML   5  0.45715  0.96900     6.08 
SOST KO 12 month WT         AP   2  1.00818  3.25363  2076.82 
SOST KO 12 month WT         ML   2  0.43859  1.41544   903.49 
 SOST KO 6 month KO         AP   4  0.60431  1.38656    14.30 
 SOST KO 6 month KO         ML   4  0.83292  1.91111    19.71 
 SOST KO 6 month WT         AP   6  0.73530  1.47058     6.85 
 SOST KO 6 month WT         ML   6  0.56604  1.13206     5.27 
SOST TG 6 month DEF         AP   9  0.53894  0.96328     2.85 
SOST TG 6 month DEF         ML   9  0.52753  0.94288     2.79 
 SOST TG 6 month TG         AP   2  0.24544  0.79209   505.60 
 SOST TG 6 month TG         ML   2  0.28073  0.90596   578.28 
 SOST TG 6 month WT         AP  11  0.52152  0.88798     2.25 
 SOST TG 6 month WT         ML  11  0.56674  0.96498     2.45 
SOST TG 8 month DEF         AP   4  0.34851  0.79965     8.25 
SOST TG 8 month DEF         ML   3  0.41880  1.08280    30.62 
 SOST TG 8 month TG         AP   2  0.54497  1.75875  1122.62 
 SOST TG 8 month TG         ML   2  0.32528  1.04974   670.06 
 SOST TG 8 month WT         AP   4  0.38602  0.88569     9.13 
 SOST TG 8 month WT         ML   4  0.31422  0.72096     7.43 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 11.97, p-value = 0.887 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 0.94, p-value = 0.539 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
THERE ARE EQUAL VARIANCES. 
 
  
General Linear Model: Yield Stress versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Yield Stress, using Adjusted SS for Tests 
 
Source                             DF  Seq SS  Adj SS  Adj MS     F      P 
Genotype+Phenotype                  9   26321   26285    2921  0.64  0.757 
Bend Direction                      1    3815     196     196  0.04  0.836 
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Genotype+Phenotype*Bend Direction   9   31676   31676    3520  0.77  0.640 
Error                              77  350029  350029    4546 
Total                              96  411840 
 
 
S = 67.4228   R-Sq = 15.01%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Yield Stress 
 
       Yield 
Obs   Stress      Fit  SE Fit  Residual  St Resid 
 70    0.674  159.668  33.711  -158.993     -2.72 R 
 72  236.161   81.305  27.525   154.856      2.52 R 
 86   39.709  149.394  47.675  -109.684     -2.30 R 
 88  259.078  149.394  47.675   109.684      2.30 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 12 month WT   4  124.47  A 
SOST TG 6 month WT   22  119.00  A 
SOST KO 6 month KO    8  115.72  A 
SOST KO 12 month KO  10  109.64  A 
SOST TG 6 month DEF  18  109.49  A 
SOST TG 8 month DEF   7  107.86  A 
SOST KO 6 month WT   12   93.57  A 
SOST TG 8 month WT    8   86.82  A 
SOST TG 8 month TG    4   80.30  A 
SOST TG 6 month TG    4   49.66  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
ML         48  101.33  A 
AP         49   97.98  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST KO 6 month KO   ML          4  159.67  A 
SOST KO 12 month WT  AP          2  149.39  A 
SOST TG 6 month DEF  ML          9  133.49  A 
SOST KO 12 month KO  AP          5  126.97  A 
SOST TG 6 month WT   ML         11  124.14  A 
SOST TG 6 month WT   AP         11  113.86  A 
SOST TG 8 month DEF  AP          4  113.50  A 
SOST KO 6 month WT   ML          6  105.84  A 
SOST TG 8 month DEF  ML          3  102.22  A 
SOST KO 12 month WT  ML          2   99.55  A 
SOST TG 8 month WT   AP          4   97.15  A 
SOST TG 8 month TG   AP          2   93.54  A 
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SOST KO 12 month KO  ML          5   92.32  A 
SOST TG 6 month DEF  AP          9   85.50  A 
SOST KO 6 month WT   AP          6   81.30  A 
SOST TG 8 month WT   ML          4   76.48  A 
SOST KO 6 month KO   AP          4   71.78  A 
SOST TG 8 month TG   ML          2   67.07  A 
SOST TG 6 month TG   ML          2   52.50  A 
SOST TG 6 month TG   AP          2   46.81  A 
 
Means that do not share a letter are significantly different. 
 
Results for: BONE DATA__BLANK.MTW 
  
General Linear Model: Ultimate Str versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Ultimate Stress, using Adjusted SS for Tests 
 
Source                             DF  Seq SS  Adj SS  Adj MS     F      P 
Genotype+Phenotype                  9   37589   37721    4191  1.97  0.054 
Bend Direction                      1    2877    3329    3329  1.57  0.214 
Genotype+Phenotype*Bend Direction   9   12980   12980    1442  0.68  0.726 
Error                              77  163621  163621    2125 
Total                              96  217066 
 
 
S = 46.0971   R-Sq = 24.62%   R-Sq(adj) = 6.02% 
 
 
Unusual Observations for Ultimate Stress 
 
     Ultimate 
Obs    Stress      Fit  SE Fit  Residual  St Resid 
 61    62.133  162.670  23.049  -100.537     -2.52 R 
 72   236.161  141.903  18.819    94.258      2.24 R 
 73    52.105  137.824  18.819   -85.720     -2.04 R 
 86   103.847  185.806  32.596   -81.959     -2.51 R 
 88   267.766  185.806  32.596    81.959      2.51 R 
 
R denotes an observation with a large standardized residual. 
 
  
Probability Plot of SRES1 
 
NORMALITY IS VERIFIED. 
   
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
95% Bonferroni confidence intervals for standard deviations 
 
                          Bend 
 Genotype+Phenotype  Direction   N    Lower    StDev    Upper 
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SOST KO 12 month KO         AP   5  0.49657  1.05255     6.60 
SOST KO 12 month KO         ML   5  0.54568  1.15664     7.25 
SOST KO 12 month WT         AP   2  1.10186  3.55595  2269.79 
SOST KO 12 month WT         ML   2  0.18697  0.60339   385.15 
 SOST KO 6 month KO         AP   4  0.19776  0.45376     4.68 
 SOST KO 6 month KO         ML   4  0.46975  1.07781    11.11 
 SOST KO 6 month WT         AP   6  0.57795  1.15589     5.38 
 SOST KO 6 month WT         ML   6  0.65096  1.30190     6.06 
SOST TG 6 month DEF         AP   9  0.76096  1.36011     4.03 
SOST TG 6 month DEF         ML   9  0.60005  1.07251     3.18 
 SOST TG 6 month TG         AP   2  0.48675  1.57086  1002.69 
 SOST TG 6 month TG         ML   2  0.45346  1.46340   934.10 
 SOST TG 6 month WT         AP  11  0.47433  0.80764     2.05 
 SOST TG 6 month WT         ML  11  0.43955  0.74842     1.90 
SOST TG 8 month DEF         AP   4  0.73690  1.69079    17.43 
SOST TG 8 month DEF         ML   3  0.33729  0.87206    24.66 
 SOST TG 8 month TG         AP   2  0.31761  1.02501   654.27 
 SOST TG 8 month TG         ML   2  0.48283  1.55820   994.61 
 SOST TG 8 month WT         AP   4  0.33142  0.76042     7.84 
 SOST TG 8 month WT         ML   4  0.39148  0.89824     9.26 
 
 
Bartlett's Test (Normal Distribution) 
Test statistic = 16.06, p-value = 0.653 
 
 
Levene's Test (Any Continuous Distribution) 
Test statistic = 1.37, p-value = 0.167 
 
  
Test for Equal Variances: SRES1 versus Genotype+Phenotype, Bend Direction  
 
EQUAL VARIANCES IS CONFIRMED. 
 
  
General Linear Model: Ultimate Str versus Genotype+Phe, Bend Directi  
 
Factor              Type   Levels  Values 
Genotype+Phenotype  fixed      10  SOST KO 12 month KO, SOST KO 12 month WT, 
                                   SOST KO 6 month KO, SOST KO 6 month WT, SOST 
                                   TG 6 month DEF, SOST TG 6 month TG, SOST TG 
                                   6 month WT, SOST TG 8 month DEF, SOST TG 8 
                                   month TG, SOST TG 8 month WT 
Bend Direction      fixed       2  AP, ML 
 
 
Analysis of Variance for Ultimate Stress, using Adjusted SS for Tests 
 
Source                             DF  Seq SS  Adj SS  Adj MS     F      P 
Genotype+Phenotype                  9   37589   37721    4191  1.97  0.054 
Bend Direction                      1    2877    3329    3329  1.57  0.214 
Genotype+Phenotype*Bend Direction   9   12980   12980    1442  0.68  0.726 
Error                              77  163621  163621    2125 
Total                              96  217066 
 
 
S = 46.0971   R-Sq = 24.62%   R-Sq(adj) = 6.02% 
 
 
Unusual Observations for Ultimate Stress 
 
     Ultimate 
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Obs    Stress      Fit  SE Fit  Residual  St Resid 
 61    62.133  162.670  23.049  -100.537     -2.52 R 
 72   236.161  141.903  18.819    94.258      2.24 R 
 73    52.105  137.824  18.819   -85.720     -2.04 R 
 86   103.847  185.806  32.596   -81.959     -2.51 R 
 88   267.766  185.806  32.596    81.959      2.51 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Genotype+Phenotype    N    Mean  Grouping 
SOST KO 6 month KO    8  175.11  A 
SOST TG 6 month WT   22  168.58  A 
SOST KO 12 month WT   4  166.16  A 
SOST TG 6 month DEF  18  154.54  A 
SOST TG 8 month DEF   7  144.34  A 
SOST KO 6 month WT   12  139.86  A 
SOST TG 8 month TG    4  139.56  A 
SOST KO 12 month KO  10  134.99  A 
SOST TG 8 month WT    8  116.33  A 
SOST TG 6 month TG    4   98.74  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Bend 
Direction   N    Mean  Grouping 
AP         49  150.72  A 
ML         48  136.92  A 
 
Means that do not share a letter are significantly different. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
                     Bend 
Genotype+Phenotype   Direction   N    Mean  Grouping 
SOST KO 6 month KO   ML          4  200.67  A 
SOST KO 12 month WT  AP          2  185.81  A 
SOST TG 6 month WT   AP         11  169.64  A 
SOST TG 6 month WT   ML         11  167.51  A 
SOST TG 8 month DEF  AP          4  162.67  A 
SOST TG 6 month DEF  AP          9  162.45  A 
SOST KO 6 month KO   AP          4  149.56  A 
SOST KO 12 month KO  AP          5  148.20  A 
SOST TG 6 month DEF  ML          9  146.64  A 
SOST KO 12 month WT  ML          2  146.51  A 
SOST KO 6 month WT   AP          6  141.90  A 
SOST TG 8 month TG   ML          2  141.38  A 
SOST KO 6 month WT   ML          6  137.82  A 
SOST TG 8 month TG   AP          2  137.73  A 
SOST TG 8 month WT   AP          4  135.41  A 
SOST TG 8 month DEF  ML          3  126.00  A 
SOST KO 12 month KO  ML          5  121.79  A 
SOST TG 6 month TG   AP          2  113.85  A 
SOST TG 8 month WT   ML          4   97.24  A 
SOST TG 6 month TG   ML          2   83.64  A 
 
Means that do not share a letter are significantly different. 
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APPENDIX D: Epoxy Embedding and Metallographic Polishing 
 
Epoxy Embedding 
Three-point bending generally results in an oblique fracture which is not suitable for 
analysis techniques such as nanoindentation. In order to allow for future work to be 
conducted on the samples, bones were embedded in epoxy and metallographically 
polished to an appropriate level of smoothness that would be suitable for 
nanoindentation. 
 
Sample Preparation 
 
Following bending and refreezing, proximal femur halves were dehydrated in increasing 
concentrations of alcohol, to remove remaining moisture from the samples, after being 
allowed to thaw. 70% isopropyl alcohol was used and was diluted to varying percentages 
with distilled water. Bones were initially placed in individual vials of 50% isopropyl and 
50% distilled water for one hour, immediately followed by increasing concentrations of 
60%, 70%, 80%, 90%, and 100% isopropyl. After this process had been completed, 
bones were grouped based on treatment type for embedding. The amount of bones per 
group varied between the treatments and the epoxy pucks that were made contained 
either all left or right femurs to allow for easier measurement and record keeping. Figure 
D.1 depicts a breakdown of the different epoxy pucks with the corresponding mouse 
numbers. 
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9198L 9200L 9201L
9202L 9203L 
PUCK 1 
 
     
   
9198R 9200R 9201R 
9202R 9203R 
PUCK 2 
 
     
   
9207L 9208L 9209L
9238L 9239L 
PUCK 3 
 9240L
 
     
   
9207R 9208R 9209R 
9238R 9239R 
PUCK 4 
 9240R 
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7592L 7544L 7593L
7594L 7565L 
PUCK 5 
 
     
   
7592R 7544R 7593R 
7594R 7565R 
PUCK 6 
 
   
   
9296L 9293L 
7545L 7564L
PUCK 7 
 
   
   
9296R 9293R 
7545R 7564R 
PUCK 8 
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8642L 8658L 8641L
8601L 8587L 
PUCK 9 
 
     
   
8641R 8658R 8642R 
8601R 8587R 
PUCK 10 
 
     
   
8600L 8656L 8657L
8640L 8599L 
PUCK 11 
 
     
   
8656R 8657R 8599R 
8600R 8640R 
PUCK 12 
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9530L 9295L 
9294L 9528L
PUCK 13 
 
   
   
9294R 9530R 
9528R 9295R 
PUCK 14 
 
     
   
9526L 9527L 9529L
8602L 8603L 
PUCK 15 
 8643L
 
     
   
9526R 9527R 9529R 
8602R 8603R 
PUCK 16 
 8643R 
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Figure D.1: Individual pucks with bone groupings. 
 
Aluminum cylindrical tubes were used to hold and effectively separate each bone during 
embedding. Each sample was checked to ensure that anatomical variations would not 
compromise or impede proper fit in the holding fixture (to be discussed in detail later).  
Improper fit was typically caused by a diaphysial cortical diameter greater than that of the 
sample holder or a large protrusion of the third (lateral) trochanter (Figure D.2). Many of 
the SOST KO samples had a diameter that was too large to fit into the most frequently 
used tubing size, a larger size aluminum cylindrical tube was used. This technique was 
useful for the larger, thicker samples however, there were incidences where the smaller 
 
     
   
5588L 5589L 5592L
5599L 8007L 
PUCK 17 
 8008L
 
     
   
8008R 5589R 5599R 
5588R 8007R 
PUCK 18 
 5592R 
 
   
   
5598L 5593L 
5597L 5590L
PUCK 19 
 
   
   
5598R 5593R 
5597R 5590R 
PUCK 20 
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SOST TG bones did not fit into the initial size tubes. This issue was the result of an 
excessive protrusion from the third trochanter and was alleviated by carefully removing 
this anatomical feature using a razor blade. Small slices from the lateral side of the 
trochanter were removed until the bone fit into the holding tube. Larger tubes were not 
used in this instance because the instability of the bone within the holding tube was found 
to cause issues during embedding. Additionally, future work will be primarily interested 
in the cortical surfaces of the diaphysis, the removal of the third trochanter was not 
believed to negatively affect the integrity and/or future testability of the samples. 
 
 
Figure D.2:  Third trochanter of the mouse femur [74]. 
 
Custom Sample Holder 
 
Custom sample holders were fabricated to allow for proper and consistent placement of 
bones when embedded in epoxy. Holders also allowed for accurate identification of 
individual bones. Aluminum cylindrical tube was cut using a tubing cutter to the 
appropriate length of each bone, such that the head of the femur rested on the upper edge 
of the tube (Figure D.3). The cut pieces were bored using a 30 gauge screw driver to 
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widen the crimped end(s) that occurred due to the cutting process. In order to remove any 
remaining debris artifacts from cutting, tubes were sonicated in an ethanol bath for 15 
minutes. Bones were checked for fit, as described previously, and tubes were glued 
together using super glue in order to create one object that would support all bones from a 
given treatment group (Figure D.4). One tube in each group was marked with a sharpie. 
This mark was visible through the hardened epoxy puck and allowed for identification of 
individual bones following embedding.  
 
 
Figure D.3: Sample holding tube containing bone during test fit. 
 
 
Figure D.4: Sample holding object with bones in place prior to embedding. 
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Sample Casting  
 
After dehydration, the mouse femurs were removed and placed in aluminum tubing 
(DiameterInner = 5/32” or 3/16”), the diaphysis contained within the tube and the femoral 
head resting just outside and above the tube.  Immediately prior to casting, samples were 
placed and centered, fracture surface down, in a clean casting mold cup, Part No. 
(Buehler, Lake Bluff, IL). Samples were cast using EPO-Thin Low Viscosity Epoxy 
Resin, Part No. 20-8140-032 (Buehler, Lake Bluff, IL) and EPO-Thin Low Viscosity 
Epoxy Hardener, Part No. 20-8142-064 (Buehler, Lake Bluff, IL), which were combined 
at a ratio of 100 parts resin to 36 parts hardener by weight.   
A clean cup was placed on a digital scale and tared. Epoxy was then poured into the cup 
to the appropriate weight to make the desired number of pucks (Figure D.5). Hardener 
was then added to the weighed epoxy until the final weight was reached such that the 
100:36 ratio was achieved (Figure D.6). The epoxy mixture was then gently stirred with a 
popsicle stick, avoiding creation of air bubbles, until the mixture became consistent in 
color (Figure D.7). At this point, working time was approximately 20 minutes which 
allowed ample time sample placement and pouring. Samples holders, already containing 
bones, were then placed in their respective mounting cups within a vacuum 
container/pump assembly (Model #: UN7260.3, KNF Neuberger, Inc., Trenton, NJ) 
(Figure D.8). Epoxy was slowly poured into each cup until the samples were completely 
covered by approximately 1 centimeter of epoxy. Following the addition of epoxy, many 
samples began floating out of their respective mounting tubes. These bones were gently 
pushed back into place using forceps to regain their initial positioning. This was done to 
insure that all bones surfaces to be polished and subsequently tested were close in 
157 
 
proximity, alleviating the need for repolishing between testing. Once all bones were 
returned to their correct place, a gentle vacuum was applied for 5 minutes followed by a 
period of no vacuum, which allowed for verification that all bones were still in the proper 
place. This process was repeated 4 times resulting in a total time of 20 minutes that 
samples were exposed to the vacuum. Vacuuming was conducted to remove air bubbles 
that were present within the epoxy puck. Once this was complete, samples were removed 
from the pump assembly and allowed to cure for a period of 24-48 hours and removed 
from molding cups. This resulted in hardened epoxy pucks which could then be polished 
to the appropriate level of smoothness required for future testing (Figure D.9). 
 
Figure D.5: Digital scale showing final weight of epoxy added. 
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Figure D.6: Digital scale showing final weight of epoxy and hardener mixture. 
 
 
 
Figure D.7: Mixing of cup filled with epoxy and hardener using popsicle stick. 
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Figure D.8: Vacuum container/pump assembly used to remove air bubbles from samples. 
 
 
Figure D.9: A sample cast in epoxy mold (unpolished).   
 
Metallographic Polishing 
 
In order to create a flat, smooth testing surface for nanoindentation, sample pucks were 
polished metallographically. To obtain this mirrored surface, multiple grinding and 
polishing steps were conducted. Initially, pucks were ground using a 120 grit belt sander. 
This course grit allowed for exposure of cortical bone surface, which was the region of 
interest. Following exposure of the cortical surface, successive grits of 240, 320, 400, and 
600 were used. Each step was conducted until the previous sanding lines were removed. 
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This was accomplished with unidirectional strokes along the sand paper. Each subsequent 
sanding was done at 90 degrees to the previous grit. This allowed for identification of 
when each step was complete. In order to prevent deep scoring of samples, the sand paper 
belt was adequately wetted and minimal pressure was applied to the sample during 
sanding. Visual assessment of the samples was done using a microscope following 
washing with ethanol.  
Once the samples were adequately sanded using the 5 grits, they were then 
metallographically polished with 0.3 micron (Buehler # 40-6249) and 0.05 micron 
suspension (Buehler # 40-6377-064). Polishing pads (Buehler # 40-1008) were placed on 
the polishing wheel and 0.03 micron suspension was mixed with distilled water for 
application to pad. The pad was then lightly moistened with Forgeng Solution and the 
motor was set to 200 rpm. Samples were polished in a circular or figure eight pattern. 
Following liberal polishing at the 0.3 micron level, samples were visually assessed for 
removal of all 600 grit sanding lines. Once these lines were completely removed from the 
cortical bone surface samples were moved to the 0.05 Alumina Oxide micron polishing 
step. The suspension formulation and pad preparation was conducted the same as the 0.3 
micron level, except the polishing pad (Allied High Tech # 90-500-350) was a magnetic 
pad, rather than adhesive backed. The sample was polished until there was uniform 
polishing as evident by visual assessment. The 0.05 step provided allowed for 
identification of bone structures and sites of remodeling and is recognized as an adequate 
level of surface roughness for nanoindentation. 
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Imaging 
Images of polished pucks were taken using a microscope and camera assembly to show 
the progression through the polishing steps (Figures D.10 – D.16). Upon microscope 
assessment, there were apparent differences between treatment types and images were 
taken to show these observations (Figures D.17 - D.36). Utilization of this system did not 
allow for capture of the entire bone, but image analysis was not a primary goal of this 
study. As such, only representative images were taken. 
 
 
Figure D.10: Epoxy Puck not finished polishing as indicated by inconsistent line patterns. 
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Figure D.11: Epoxy Puck 6 polished at 240 grit. 
 
Figure D.12: Epoxy Puck 11 polished at 320 grit. 
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Figure D.13: Epoxy Puck 9 polished at 400 grit. 
 
Figure D.14: Epoxy Puck 10 polished at 600 grit. 
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Figure D.15: Epoxy Puck 1 polished at 0.3 micron. 
 
Figure D.16: Epoxy Puck 1 polished at 0.05 micron. 
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Figure D.17: SOST TG 6 month bone (# 9296) polished to 0.3 micron. 
 
Figure D.18: SOST TG 6 month bone (# 9296) polished to 0.05 micron. 
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Figure D.19: SOST DEF 6 month bone (# 8601) polished to 0.3 micron. 
 
Figure D.20: SOST DEF 6 month bone (# 8601) polished to 0.05 micron. 
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Figure D.21: WT 1 bone (# 8599) polished to 0.3 micron. 
 
Figure D.22: WT 1 bone (# 8599) polished to 0.05 micron. 
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Figure D.23: SOST TG 8 month bone (# 5592) polished to 0.3 micron. 
 
Figure D.24: SOST TG 8 month bone (# 5592) polished to 0.05 micron. 
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Figure D.25: SOST DEF 8 month bone (# 5589) polished to 0.3 micron. 
 
Figure D.26: SOST DEF 8 month bone (# 5589) polished to 0.05 micron. 
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Figure D.27: WT 2 bone (# 5598) polished to 0.3 micron. 
 
Figure D.28: WT 2 bone (# 5598) polished to 0.05 micron. 
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Figure D.29: SOST KO 6 month bone (# 9198) polished to 0.3 micron.  
 
Figure D.30: SOST KO 6 month bone (# 9198) polished to 0.05 micron. 
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Figure D.31: WT 3 bone (# 9207) polished to 0.3 micron.  
 
Figure D.32: WT 3 bone (# 9207) polished to 0.05 micron. 
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Figure D.33: SOST KO 12 month bone (# 7592) polished to 0.3 micron. 
 
Figure D.34: SOST KO 12 month bone (# 7592) polished to 0.05 micron. 
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Figure D.35: WT 4 bone (# 7564) polished to 0.3 micron. 
 
Figure D.36: WT 4 bone (# 7564) polished to 0.05 micron. 
